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Abstract 
 
This study was carried out in Gadarif State, Eastern Sudan, during 
the period from December 2004 to July 2005. The study was designed to 
isolate and identify bacteria that cause enteric fever in humans in Gadarif 
State, and to determine the antibiograms of the isolated bacteria to the 
commonly used antibiotics. The study involved sick individuals in the 
community, which included different ages and genders. 
From 71 patients, who were diagnosed as suffering from enteric 
fever and had significant titres for Widal test, faecal and blood samples 
were collected. Specimens from 24 patients were dropped because they 
did not give growth of significant bacteria. Isolates from the remaining 
47 patients were further characterised and their susceptibility to various 
antibiotics was determined.         
    The main bacteria of enteric fever in Gadarif State was S. paratyphi B,  
while organisms such as Proteus and Pseudomonas spp, were isolated 
from some specimens.  
Fourteen of S. paratyphi B isolates showed resistance to 
ciprofloxacin while the other nine isolates showed multidrug-resistance. 
All isolates were highly susceptible to chloramphenicol.  
In this study it was observed that the disease was more common 
among females than males. This was perhaps due to lack of household 
and personal hygiene in poor communities, beside the development of 
carriers. Women are more exposed to compost, waste, food and 
contaminated water supplies in Gadarif State.           
   
 
 
 
 
 
 
 
 
 
 
 
 
 
  ﺔﺍﻷﻁﺭﻭﺤ ﻤﻭﺠـﺯ
ﺃﺠﺭﻴﺕ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴِﺔ  ﻓﻲ ﻭﻻﻴِﺔ ﺍﻟﻘﻀﺎﺭﻑ، ﺒﺸﺭﻕ ﺍﻟﺴﻭﺩﺍﻥ، ﻓﻲ ﺍﻟﻔﺘﺭِﺓ 
 ﻭﺘﺤﺩﻴﺩ ﺨﺼﺎﺌﺹﺍﻟﺩﺭﺍﺴﺔ  ﻟﻌﺯل ﺕ ﻫﺩﻓ. 5002 ﺇﻟﻰ ﻴﻭﻟﻴﻭ 4002ِﻤﻥ ﺩﻴﺴﻤﺒﺭ 
ﺠﺭﺍﺀ ﻤﻥ ﺜﻡ ْﺍﺍﻟﺒﻜﺘﻴﺭﻴﺎ ﺍﻟﻤﺴﺒﺒﺔ  ﻟﻠﺤﻤﻰ ﺍﻟﻤﻌﻭﻴﺔﹶ ﻓﻲ ﺍﻟﺒﺸِﺭ ﻓﻲ ﻭﻻﻴِﺔ ﺍﻟﻘﻀﺎﺭﻑ، ﻭ
 ﺸﻤﻠﺕ. ﺯﻭﻟِﺔ  ﻟﻠﻤﻀﺎﺩﺍﺕ ﺍﻟﺤﻴﻭﻴﺔ ﺍﻷﻜﺜﺭ ﺍﺴﺘﻌﻤﺎﻻﹰﻓﺤﺹ ﺍﻟﺤﺴﺎﺴﻴﺔ  ﻟﻠﺒﻜﺘﻴﺭﻴﺎ ﺍﻟﻤﻌ
 . ﻤﻥ ﺍﻟﺠﻨﺴﻴﻥﻭﺍﻟﺩﺭﺍﺴﺔﹸ ﺍﻷﻓﺭﺍﺩ ﺍﻟﻤﺼﺎﺒﻴﻥ ﻤﻥ ﻤﺨﺘﻠﻑ ﺍﻷﻋﻤﺎﺭ 
ﻭﻟﺩﻴﻬﻡ  ﻤﺭﻴِﻀﺎﹰ، ﺸﹸﺨﹼﺼﻭﺍ ﻜﻤﺼﺎﺒﻴﻥ ﺒﺎﻟﺤﻤﻰ ﺍﻟﻤﻌﻭﻴِﺔ ﻭﺍﺤﺩ ﻭﺴﺒﻌﻭﻥ
 ﺘﻡ ﺇﺴﺘﺒﻌﺎﺩ  ﺒﻌﺩ ﺍﻟﺯﺭﻉ ّ.ﺒﺭﺍﺯﻴﺔ ﻭﻋﻴﻨﺎﺕ ﺩﻡ ﻋﻴﻨﺎﺕﻋﻴﺎﺭ ﻤﻌﺘﺩ ﻹﺨﺘﺒﺎﺭ ﻓﻴﺩل ﺍﺨﺫﺕ 
ﻤﺘﺒﻘﻲ ﻤﻥ ﻠﻟ.  ﻨﻤﻭ ﺍﻟﺒﻜﺘﻴﺭﻴﺎ ﺍﻟﻤﺴﺒﺒﺔ ﻟﻠﻤﺭﺽﺘﻜﺸﻑ ﻋﻥ ﻭﺠﻭﺩﻨﻬﺎ ﻟﹶﻡ  ﻋﻴﻨﺔ ﻷ42
 ﻭﺇﺠﺭﺍﺀ ﺇﺨﺘﺒﺎﺭ ﻓﺤﺹ ﺎﺍﻟﻤﻌﺯﻭﻟﺔﺍﻟﺒﻜﺘﻴﺭﻴﺘﺤﺩﻴﺩ ﺨﺼﺎﺌﺹ  ﺘﻡ 74ﺍﻟﻌﻴﻨﺎﺕ ﺍﻟﺒﺎﻟﻎ 
 .ﺤﺴﺎﺴﻴﺘﻬﺎ ﻟﻠﻤﻀﺎﺩﺍﺕ ﺍﻟﺤﻴﻭﻴﺔ ﺍﻟﻤﺨﹾﺘﹶِﻠﻔِﺔ
 ﺍﻟﺒﺤﺙ ﺃﻥ ﺍﻟﻤﺴﺒﺏ ﺍﻟﺤﻘﻴﻘﻲ ﻟﻠﺤﻤﻰ ﺍﻟﻤﻌﻭﻴِﺔ ﻓﻲ  ﺨﻼل  ﻟﻘﺩ ﻭﻀﺢ ﻤﻥ
ﻭ ﻗﺩ ﺘﻡ ﻋﺯل ﺒﻌﺽ . ﻨﻴﻼﹼ ﻨﻅﻴﺭﺓ ﺍﻟﺘﺎﻴﻔﻭﻴﺩ ﺏ ﻤﻭﻜﺘﻴﺭﻴﺎ ﺴﺎﻟﻭﻻﻴِﺔ ﺍﻟﻘﻀﺎﺭﻑ ﻫﻭ ﺒﺎ
ﻤﻥ ﺒﻌﺽ ﻟﻤﺭﺽ ﻤﺜل ﺠﻨﺱ ﺍﻟﻤﺘﻘﻠﱢﺒﺔ ﻭ ﺠﻨﺱ ﺍﻟﺯﺍﺌﻔﺔ،ﺍﺴﺒﺏ ﺍﻟﺘﻲ ﻻ ﺘﺍﻟﺒﺎﻜﺘﻴﺭﺍ 
  .ﺍﻟﻌﻴﻨﺎﺕ ﺍﻟﻤﻭﺠﺒﺔ ﻹﺨﺘﺒﺎﺭ ﻓﻴﺩل
ﻤﻘﺎﻭﻤﺔ ﻟﻌﻘﺎﺭ  ﻜﺎﻨﺕ ﻨﻅﻴﺭﺓ ﺍﻟﺘﺎﻴﻔﻭﻴﺩ ﺏﺃﺭﺒﻌﺔ ﻋﺸﺭ ﻋﺘﺭﻩ ﻤﻥ 
ﺘﻬﺎ ﻟﻠﻌﺩﻴﺩ ﻤﻥ ﺍﻟﻤﻀﺎﺩﺍﺕ ﻤﻭ ﺃﺨﺭﻯ ﺃﻅﻬﺭﺕ ﻤﻘﺎ ﻋﺘﺭﺍﺕ9ﺒﻴﻨﻤﺎ . ﺍﻟﺴﻴﺒﺭﻭﻓﻠﻭﻜﺴﺎﺴﻴِﻥ
 ﺍﻟﻤﻌﺯﻭﻟﺔ ﺇﺴﺘﺠﺎﺒﺕ ﻟﻌﻘﺎﺭ ﺍﻟﻜﻠﻭﺭﺍﻤﻔﻴﻨﻴﻜﻭل ﺒﺩﺭﺠﺔ ﻌﺘﺭﺍﺕﺇﻻﹼ ﺃﻥ ﺠﻤﻴﻊ ﺍﻟ. ﺍﻟﺤﻴﻭﻴﺔ
 .ﻋﺎﻟﻴﺔ
ﻟﻭﺤﻅ ﻓﻲ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ ﺃﻥ ﺍﻟﻤﺭﺽ ﻜﹶﺎﻥ ﺃﻜﺜﺭ ﺸﻴﻭﻋﺎﹰ ﺒﻴﻥ ﺍﻹﻨﺎﺙ ِﻤﻥ 
ﻋﻠﻰ ﺍﻟﺼﻌﻴﺩ ﺍﻟﺸﺨﺼﻲ،  ﻀﻌﻑ ﺍﻟﻌﻨﺎﻴﺔ ﺍﻟﺼﺤﻴﺔ ﺒﺴﺒﺏ  ﻴﻜﻭﻥ ﺫﻟﻙ ﺭﺒﻤﺎ، ﺍﻟﺫﻜﻭﺭ
ﻤﻤﺎ ﻴﺤﺩﺙ ﺍﻟﻌﺩﻭﻯ ﻭﻅﻬﻭﺭ ﺤﺎﻤﻼﺕ  ﻌﺎﺕ ﺍﻷﻜﺜﺭ ﺘﺨﻠﻔﺎﹰ ﻭﺍُﻷﺴﺭﻱ ﻓﻲ ﺍﻟﻤﺠﺘﻤ
 ﻭ  ًﺍﻟﺒﻘﺎﻴﺎ ﺍﻟﻤﺘﺤﻠﻠﺔ ﻤﻥ ﺍﻷﻁﻌﻤﺔ ،ﻭ  ﺍﻟﻤﻠﻭﺙ ﺃﻜﺜﺭ ﺘﻌﺭﻀﺎ ﻟﻠﻐﺫﺍﺀﺍﻟﻨﺴﺎﺀ. ﻟﻠﻤﺭﺽ
 .ﺍﻟﻨﻔﺎﻴﺎﺕ،  ﻭﻤﺼﺎﺩﺭ ﺍﻟﻤﻴﺎﻩ ﺍﻟﻤﻠﻭﺜﺔ ﻓﻲ ﻭﻻﻴِﺔ ﺍﻟﻘﻀﺎﺭﻑ
CHAPTER ONE  
 
1. Introduction 
Salmonellae acquired by the oral route are often pathogenic for 
humans and animals. They may be transmitted from animals and animal 
products to humans, where they cause enteritis, systemic infection, and 
enteric fever (Brooks, Bult, Morse, 1998). Interestingly, humans are the 
sole reservoir for Salmonella typhi which causes the most dangerous 
form of salmonellosis, typhoid fever, in man.       
           Enteric fever is an acute infectious disease characterized by 
abdominal symptoms and enlargement of spleen. It may be presented  
with the history of prolonged pyrexia of obscure origin (Elfaki, 1987).          
Enteric fever (typhoid) is classically caused by Salmonella enterica 
serotype typhi, but a similar syndrome may be caused with Salmonella 
paratyphi A,B and C (Chandel et al., 2000). 
 following the ingestion of contaminated food or water the bacteria 
penetrate the intestinal mucosa to gain entry to the lymphatics and blood 
stream, where they produce an initial bacterimic phase, exhibiting 
systemic symptoms that last for about a week. The organisms then 
appear in the alimentary tract, possibly via bile secretion (MacSween and 
Whaley, 1992). Bile is a good culture medium for the bacteria, which 
multiply abundantly in the gall bladder and are discharged continuously 
into the intestine where they involve the peyer’s patches and lymphoid 
follicles of the ileum (Ananthanarayan and Paniker, 1997). Transient 
nephritis was diagnosed clinically and biochemically in Sudanese 
patients suffering from typhoid fever in Gezira area (Musa, Salih and 
Abu Asha,1981). 
          Salmonella paratyphi, is also an exclusively 
human health problem and its clinical and 
pathological features are very similar to those of 
typhoid fever, in almost all cases except it is, milder 
in degree and largely confined to the distal ileum. 
Here, too, the carrier state provides the reservoir of 
infection (McSween and Whaley, 1992). 
Salmonella enterica serotype typhi is endemic in developing 
countries in Africa, south and Central America, and the Indian 
subcontinent, with an estimated incidence of 33 million cases each year. 
By contrast, in developed countries such as United Kingdom or the USA, 
the incidence is much lower, and most cases are in travellers returning 
from endemic areas (Threlfall and Ward, 2001). 
S.typhi, S.paratyphi A and S.paratyphi B are the common cause of 
typhoid and paratyphoid in Sudan (Khan,1962) and S.paratyphi C has 
never been reported from man in this country, but it was isolated from 
lizards (Krik,1966). S.typhi was isolated from medical students of the 
University of Khartoum (Yousif and Salim ,1966).  
Diagnosis of enteric fever by Widal test, need to be judged in 
association with knowledge of normal O and H agglutinins titres in local 
population.  In Sudan, a titre of 1:160 or more for O somatic antigen is 
considered as evidence of typhoid fever (Elfaki, 1987).      
1.1 Objectives: 
The main objectives of this study were: 
1- To determine the type of bacteria causing enteric fever in 
humans living in areas in the vicinity of Gadarif town. 
2- To compare Widal test with isolation procedures in 
detecting the disease.  
3- To determine the susceptibility of isolated bacteria to 
antibiotics commonly used for treating enteric fever 
 
 
 
 
 
 
  
CHAPTER TWO 
2. LITRETURE REVEW 
2.1 History of enteric fever: 
The term enteric fever includes typhoid caused 
by Salmonella typhi and paratyphoid fever caused by 
Salmonella paratyphi A, B and C.       
Typhoid fever was once prevalent all over the 
world and was not well demarcated from other 
prolonged fevers. (Bretonneau, 1826), who identified 
the intestinal lesions, presented a detailed study of 
the disease (Youmans, Paterson and Sommers, 1986). 
The name typhoid was given by Lois (1829), to 
distinguish it from typhus fever. (Budd, 1856) pointed 
out that the disease was transmitted through the 
excreta of patients. (Eberth, 880), described the 
typhoid bacillus and (Gaffy, 1884), isolated it in pure 
culture. (Metchnickoff and Besredica, 1900), 
confirmed its causative role by infecting apes 
experimentally by injecting the organism (Hyde, 
1995). 
Salmonella paratyphi A was isolated by Gwyn 
(1898); S.  paratyphi B (S. schottmülleri) by Achared 
and Bensuade,(1896), and S. paratyphi C (S. 
hirschfeldi) by Uhlenhuth and Hubener (1908), from 
cases resembling typhoid fever (Ananthanarayan and 
Paniker, 1997).  
 
2.2 The Aetiology of enteric fever: 
         Enteric fever is a clinical syndrome produced 
classically by Salmonella typhi and, also at times, by 
Salmonella paratyphi A, S. schottmülleri, (formerly) 
paratyphi B and S. hirschfeldi, (formerly) paratyphi C. 
Salmonella serotypes other than those mentioned 
above can occasionally produce a clinical feature of 
enteric fever. Enteric fever produced by Salmonella 
typhi is called typhoid fever and that produced by 
Salmonella serotypes other than S. typhi is termed 
paratyphoid fever. The main typical cause of enteric 
fever is S. typhi, whereas other similar but not typical 
ones are Salmonella paratyphi organisms. 
2.2.1 Salmonella typhi: 
     Salmonella typhi is pathogenic only for man, 
causing typhoid (enteric) fever and is transmitted by 
water or food contaminated by human excreta. 
The organism does not grow on Simmons’s 
citrate medium or on minimal defined medium and 
requires tryptophane as a growth factor. It does not 
produce gas from glucose or other sugars (Krieg and 
Holt, 1984). 
2.2.2 Salmonella paratyphi A: 
Salmonella paratyphi A causes a typhoid–like 
infection. It is pathogenic only for man. The majority 
of strains do not produce hydrogen sulphide, and in 
this respect S.paratyphi A is unlike most other 
salmonellae (Krieg and Holt, 1984). 
2.2.3 Salmonella schottmülleri (formerly paratyphi B): 
The organism causes enteric fever in man and 
very rarely infects animals. It produces a slime layer 
when grown on medium containing 0.5% glucose and 
0.2 M sodium phosphate solution at pH 7 (Krieg and 
Holt, 1984). 
2.2.4 Salmonella paratyphi C: 
Salmonella paratyphi C causes mainly 
septicaemia, and also causes paratyphoid fever. 
Infection with paratyphi C is usually more 
serious than those of S. paratyphi A and S. paratyphi 
B. Virulent and multi resistant strains of S .paratyphi 
C are common in the Indian subcontinent (Ochei and 
Kolhatkar, 2000). 
2.3  Classification of Salmonella  Species: 
   Salmonellae can be classified according to 
biochemical, serological and genetical analyses.    
                                                                                                       
2.3.1 Biochemical classification: 
The salmonellae contain a single genus, 
Salmonella, and are named after the American 
microbiologist, D.E. Salmon. On the basis of 
biochemical reactions, Kauffmann proposed that 
Salmonella be classified into six subgenera (Paniker 
and Vilma, 1997).  
 Subgenus 1: 
It is the largest and medically the most important 
group that contains all the species commonly 
causing human and animal infections. It includes 
most of the serotypes S. typhi, S. cholerae-suis, S. 
paratyphi and   S. galinarum. 
 Subgenus 2: 
This subgenus contains mostly species isolated 
from reptiles for example S. salmae.  
 Subgenus 3: 
Subgenus 3 contains bacilli, formerly designated 
as “Arizona”, originally isolated from lizards but 
subsequently found in reptiles, birds, domestic 
animals and human beings. Many of them are prompt 
lactose fermenters and are subdivided into: 
Salmonella subgroup 3a S. arizona 
 
 Salmonella subgroup 3b: S. diarzona 
  
 Subgenus 4: 
Those strains are rarely encountered and may be 
considered as atypical members of subgenus 2, e.g. 
S. houtenae   
 Subgenus 5: 
An example of this subgenus is S. bongori 
 Subgenus 6:  
An example of this subgenus is S. chloaresuis subspecies 
indic (Koneman et al., 1997; Paniker and Vilma, 1997). 
 
2.3.2 Serological classification : 
(Kauffmann-White classification) 
 Salmonella subcommittee (1934), proposed that 
serology was the ultimate criterion in the 
classification of Salmonella (Barrow and Feltham, 
1993). Kauffmann-White scheme for classification 
was first developed in 1934 and it classifies 
salmonellae into different O groups or O serotypes, 
each of which contains a number of serotypes 
possessing a common O antigen not found in other O 
groups. The O groups, first defined, were designated 
by capital letters A to Z and those discovered later by 
the number (51-67) of the characteristic O antigen 
(David, Bishop and Mass 1989). 
 Beginning July, 1983 the Centre for Disease 
Control (CDC) changed the method for reporting 
Salmonella serotypes; so that all organisms identified 
as salmonellae were reported as genus and serotype, 
omitting reference to species (Koneman et al., 1997). 
Within each group, the differentiation of 
serotypes is carried out by the identification of phase 
1 and 2 flagellar antigens. 
The Kauffmann-White scheme gave species 
status to each serotype; the genus Salmonella is 
subdivided into more than 2300 serotypes containing 
different combinations of antigens (Collee et al., 
1996). Complete antigen analysis is not a routine 
procedure for clinical laboratories, but reference 
laboratories are available in most countries (Barrow 
and Feltham, 1993). 
 
2.3.3 Classification by Deoxyribonucleic Acid (DNA) 
hybridization:  
Modern taxonomical techniques, especially DNA 
studies, have shown that all the members of the 
genus Salmonella and the former genus Arizona are 
so closely related that they should all be considered 
as belonging to a single species, in a genetic, 
phylogenetic and evolutionary sense (David et al., 
1989) 
DNA hybridization studies have shown all 
salmonellae to be genetically identical (Cheesbrough, 
2000). A new species named Salmonella enterica has 
been coined to include all salmonellae. S.enterica is 
classified into seven subspecies based on DNA 
reassociation tests (Ananthanarayan and Paniker, 
1997), each with its own phenotypic characteristic 
and history (Cheesbrough, 2000). These subspecies 
are named enterica, salamae, arizona, diarizonae, 
houtenae, longori and indica. Subspecies enterica 
corresponds to the former subgenus 1 (Paniker and 
Vilma, 1997). 
This genetically based new classification system 
has not yet been widely adopted by medical 
microbiologist (Cheesbrough,2000). Deoxyribonucleic 
Acid (DNA) classification and nomenclature, while 
being taxonomically correct, would be too 
complicated for use in clinical bacteriology. For 
example, the taxonomically correct name for typhoid 
bacillus would be “Salmonella enterica, subspecies 
enterica, serotype typhi“. Therefore, the old practice 
of referring to clinically important Salmonella 
serotypes by the species name continues in clinical 
bacteriology. Important pathogens such as S. typhi, 
S. paratyphi A and B can further be typed for 
epidemiological purposes by phage susceptibility, 
biochemical properties, and bacteriocin production 
(Stratton et al., 2001).                                                                          
2.4  Morphology of Salmonella  Species: 
 Salmonellae are Gram–negative straight rods, 
0.7-15 x 2.0-5.0 µm, conferring the general definition 
of the family Enterobacteriacae, (Krieg and Holt,1984). 
With the exception of S. pullorum–gallinarum, all 
salmonellae are actively motile (Krieg and Holt, 1984; 
Barrow and Feltham,1993; Cheesbrough, 2000). They 
are motile with peritrichous flagellae (Collee et at., 
1996; Paniker and Vilma, 1997). They are non-sporing 
and with the exception of S. typhi are non-capsulated 
(Collee et al., 1996; Cheesbrough, 2000).                                       
2.5  Cultural characteristics of Salmonella Species: 
     Salmonellae are aerobic and facultatively 
anaerobic bacteria (Barrow and Feltham, 1993). They 
grow readily on simple media with a pH 6-8 and at 
temperatures of 15 - 41C (optimum 37C) (Collee et al., 
1996). Many stains are prototrophic, i.e. capable of 
growing on glucose– ammonium minimal medium, 
but some strains are auxotrophic and require minimal 
medium with one or more amino acids or vitamins, 
e.g. Cystine or nicotinamide; most S. typhi strains 
require tryptophan (Barrow and Feltham, 1993). 
   On nutrient agar and blood agar colonies are 
large, 2-3mm in diameter, low convex, smooth, grey-
white, moist, circular with entire edge, thus 
resembling the colonies of many other enterobacteria 
(Collee et al., 1996). 
 In liquid media such as peptone water and 
nutrient broth most strains give abundant growth 
with uniform turbidity. A thin surface pellicle usually 
forms on prolonged incubation. Rough (R) variants, 
which have hydrophobic surface and tend to 
agglutinate, produce a granular deposit and 
sometimes a thin pellicle (Collee et al., 1996). 
 On differential and selective solid media, 
MacConkey agar, colonies are colourless as lactose 
is not fermented. 
 Colonies of salmonellae on Salmonella-shigella 
agar medium are similar to, or smaller in size than, 
those on MacConkey agar. They are pale, colourless, 
smooth, shiny and translucent. They have a black 
centre and sometimes they are surrounded by a zone 
of clear medium (Collee et al., 1996). 
On brilliant green bismuth sulphite agar (BBSA) 
S. typhi and paratyphi B form black colonies with 
metallic sheen.  Many strains of paratyphi B form 
large mucoid colonies, or colonies surrounded by a 
thick mucoid or slime layer (Collee et al., 1996). 
On Kligler iron agar (KIA) salmonellae produce a 
yellow butt and red–pink slope due to the 
fermentation of glucose only. Cracks and bubbles in 
the medium indicate gas production from glucose 
fermentation. Gas is produced by S. paratyphi, 
(Cheesbrough, 2000). 
On selenite F-broth medium there is a change of 
colour from colourless to red. 
In brilliant green bile broth salmonellae change 
the green colour to grey. 
2.6  Biochemical reaction of Salmonella Species:  
The enteric fever group can be separated 
biochemically from other enterobacteria (Koneman, et 
al.,1997). Salmonellae ferment glucose, mannitol and 
maltose forming acid and gas. An important 
exception is S. typhi, which is anaerogenic (Krieg and 
Holt, 1984; Barrow and Feltham, 1993). Sucrose, 
salacin and lactose are usually not fermented. The 
bacteria  negative for oxidase, urease and indole 
production.  
Hydrogen sulphide is usually produced on 
Kligler iron agar (KIA), S.typhi differs from most other 
salmonellae in producing only small amounts of 
hydrogen sulphide. S. paratyphi A does not produce 
hydrogen sulphide. Citrate is usually utilized as a 
sole carbon source, but S. typhi is usually an 
important exception as it does not grow on Simon’s 
citrate medium. 
Salmonellae are positive for nitrate reduction 
and methyl red (MR) tests, but are negative for Voges 
Proskauer (VP) test,  (Krieg and Holt, 1984; Barrow 
and Feltham, 1993).  
2.7  Identification of Salmonella Species:           
The identification of Salmonella species can be 
carried out through biochemical investigation. Then 
the corresponding serotype is determined by the 
specific serotyping using the agglutination test. The 
recently developed genetic methods using 
deoxyribonucleic acid (DNA), provide important tools 
for accurate specification (Graham, et al., 1999). 
2.8  Antigenic structure of the Salmonella species: 
While salmonellae are initially detected by 
biochemical characteristics, group and species are 
identified by antigenic analysis (Brook, et al., 1998). 
Salmonella, like other bacteria, has somatic (O) 
antigens, which are lipopolysaccharide components 
of the cell wall, and flagellar (H) antigens, which are 
proteins (Mandell ,Hook and Douglas, 1985; Collee, et 
al.1996; Brook, et al., 1998). 
There are about 60 (O) antigens, and many H 
antigens, each of which is designated by number and 
letter (Mandell, et al., 1985; Paniker and Vilma, 1997; 
Brooks, et al., 1998). Certain serotypes (e.g. S. typhi) 
have a capsular or virulence (Vi) antigen composed of 
homopolymer of N-acetyl glactoseaminuronic acid 
(Mandell, et al., 1985). The presence of Vi antigen on 
the cell surface may block agglutination by anti–O 
serum (Mandell, et al., 1985). Many strains of S. typhi 
fail to agglutinate with the anti-O serum when freshly 
isolated. This is due to the presence of surface 
antigen, enveloping the O antigen (Ananthanarayan 
and Paniker, 1997). (Mandell, et al., 1985), who first 
described this antigen, believed that it was related to 
virulence and gave it the name Vi antigen. It is 
analogous to the K antigens of coliforms and is heat 
labile. Bacilli, bearing this antigen are inagglutinable 
with the O anti serum yet become agglutinable after 
boiling or heating at 60C for one hour. It is also 
destroyed by 1.0 N HCL and 0.5 N NaOH. It is 
unaffected by alcohol or 0.2% formol 
(Ananthanarayan and Paniker, 1997). Almost all 
recently isolated strains of S. typhi form Vi antigen as 
a covering layer out side their cell wall (Collee, et al., 
1996). The Vi antigen is lost in serial subculture. 
Other surface antigens include the capsular or K 
antigens, the slime (mucus) or M antigen and fimbrial 
or F antigen. Such antigens may cause difficulty in 
the serological identification of bacteria, either by 
masking the O antigens so that the bacteria are 
inagglutinable by O antibodies or by causing non–
specific cross-reaction due to their presence in 
unrelated bacteria (Cheesbrough, 2000).  
2.8.1 R antigens: 
In smooth to rough mutation The O antigens of 
Salmonellae are lost and new R antigens are revealed 
at the bacterial surface (Collee, et al., 1996).The 
antigens are the same in the R variant of different 
Salmonellae serotypes, though different from The R 
antigens of other enterobacteria, for they are 
autoagglutinable and lack serotype specificity. They 
are unsuitable for serological test (David et al., 1989).  
   The smooth–to–rough variation is associated 
with change in colony morphology and loss of the O 
antigen of virulence. The colony becomes large, 
rough, and irregular. Suspension in saline is 
autoagglutinable. Conversion into R forms occurs by 
mutation. R forms may be common in laboratory 
strains maintained by serial subcultivation (David et 
al., 1989). 
Mucoid colonies, associated with the 
development of a new mucoid or M antigen, have 
been described with S. paratyphi B and some other 
species (Ananthanarayan and Paniker, 1997). 
2.9  History of the Salmonella species: 
The genus Salmonella consists of bacilli that 
reside innately in the intestines of a large number of 
vertebrates and infect human beings, leading to 
enteric fever, gastroenteritis and septicaemia. 
The most important member of genus is S. typhi, 
the causative agent of typhoid fever. Typhoid bacillus 
was first observed by Eberth (1880), in the mesenteric 
lymph nodes and spleen of fatal cases of typhoid 
fever and was isolated by Gaffy (1884). It came to be 
known as Eberth-Gaffy bacillus or Eberthella typhi. 
Salon and Smith (1885), described a bacillus, which 
was believed to cause hog cholera. This bacillus, 
later called S. cholerae-suis, was the first of a series 
of similar organisms to be isolated from animals and 
human beings in the genus Salmonella. It was 
subsequently realized that the typhoid bacillus also 
belongs to this group, despite minor biochemical 
differences and it was reassigned the name S. 
typhi, the genus Eberthella having been abolished.  
Salmonella currently comprises over 2000 
serotypes or species, all of which are potentially 
pathogenic (Ananthanarayan and Paniker, 1997).  
2.10 Transmission of causative agent of typhoid to host: 
Human carriers provide the source of infection, there being no 
animal reservoir (MacSween and Whaley, 1992). Infection occurs 
through the ingestion of the organism in contaminated hands. Salmonella 
typhi is mainly water-borne, whilst S. paratyphi is mainly food-borne 
(Cheesbrough, 2000). 
2.11 Pathology and pathophysiology of typhoid fever:    
The main pathological changes are found in the gastrointestinal 
tract. The peyer’s patches show hyperplasia during the first week of 
typhoid, necrosis during the second week and ulceration during the third 
weak. 
Healing takes place without scaring during the fourth week. The 
ulcer is oval in the long axis of the lower ileum. There is exudate on the 
peritoneal surface. Separation of the sloughs may lead to haemorrhage 
and perforation. The incidence of ulcer bears no relationship to the 
clinical severity of the infection. The liver shows a cloudy swelling and 
typhoid nodules, which are small lesions consisting of collection of 
macrophages and lymphocytes with or without central necrosis (El-faki, 
1987). 
2.12   Pathogenicity of the aetiologic agent of typhoid fever:  
2.12.1 Pathogenesis  
The development of the disease after ingestion of Salmonella is 
influenced by the number and the virulence of the organisms and by 
multiple host factors (El-faki, 1987). 
A large number of Salmonella must be swallowed in most 
instances to produce disease in healthy human beings. Limited studies 
with several serotypes, including S. typhi, show that, in general, 106-109 
organisms must be ingested to produce symptomatic infection. However, 
in the event of infection with usually virulent organisms or in patients 
with reduced resistance, symptomatic infection may result from 
extremely small inocula. It is also known that an asymptomatic infection 
can be established with 10 to 100 times fewer organisms than are needed 
to produce symptomatic infection (Khan, et al., 1998). 
Ingested organisms pass from the mouth to the stomach. In the 
past it was thought that S. typhi gained access to the body through the 
tonsils or pharyngeal lymphatics. However, volunteers gargling large 
inocula of S. typhi, (Quails strain) have failed to acquire the disease, and 
invasion through the pharynx is thought not to occur (Youmans, et al., 
1986). 
In the stomach salmonellae are exposed to gastric acid and low 
pH, which reduces the number of the viable organism. Most salmonellae 
are killed rapidly at pH 2, which is readily achieved in the normal 
stomach. Viable bacilli that survive then pass into small intestine, where 
the organism is further reduced in number or eliminated entirely. The 
antimicrobial activity observed in the small bowel is related, at least in 
part, to the normal microbial flora of the intestine, which elaborates 
short-chain fatty acids and perhaps other substances capable of killing or 
inhibiting growth of Salmonella. Salmonella that survives the 
antibacterial mechanisms in the stomach and upper small bowel may 
multiply in the small intestine (Brooks et al., 1998). 
Multiplication of salmonellae in the intestinal tract may be 
asymptomatic, associated only with transient excretion of organisms in 
stool, or symptomatic, associated with clinical manifestations of 
enterocolitis (acute gastroenteritis), enteric fever, or bacteraemia (Ochei 
and Kolhatkar, 2000). 
Local factors in the stomach and upper intestinal tract are 
important determinants of the disease. Factors that neutralize the low pH 
of the stomach or decrease the time the pathogen is exposed to stomach 
acid diminish local bactericidal action and increase the probability that 
an infectious inoculum will reach the small intestine. It has been 
suggested that ingestion of organisms in food allows for long exposure to 
gastric acid, thereby necessitating the presence of relatively larger 
inoculum to produce disease, while water and other liquids, which have a 
fast gastric transient time, may be less heavily contaminated and still 
cause disease (Youmans, et al., 1986). 
The small intestine provides other protective mechanisms through 
motility and normal flora. Alteration of intestinal flora by antibiotics 
such as streptomycin markedly reduces the size of the inoculum required 
to produce Salmonella infection in animals and man and prolongs the 
convalescent carrier state (Mandell, et al., 1985). Antimicrobial drugs 
affect not only the infecting microorganisms but also susceptible 
members of normal flora of the body. An imbalance is thus created that, 
in itself, may lead to disease (Brooks et al., 1998). 
Age is an important determinant of the disease produced by 
salmonellae. The influence of age on incidence may be attributed to the 
immunity of humoral and cellular immune mechanism, diminished 
antibacterial action of the normal intestinal flora, high frequency of 
faecal oral contamination, or other factors. In some instances, increasing 
resistance with age is related to immunity consequent to previous 
exposure to the organism, even though the disease has not been imposed 
(Khan, et al., 1998). 
Typhoid fever also occurs with increased frequency amongst the 
young in areas of world such as Mexico, Chile, India, Southeast Asia, 
and parts of Africa where the disease is endemic. In these areas, adults 
have acquired substantial resistance through repeated exposure to the 
organism. However, in more developed areas where enteric fever is not 
endemic, there is opportunity of repeated subclinical infection, and the 
incidence is not age-related (Sood, et al., 1999). 
Patients with impaired cellular humoral immune mechanisms are 
at increased risk for the development of salmonellosis. Impairment of 
host defenses caused by malnutrition, malignancy, or therapeutic 
measures such as corticosteroid or immunosuppressive therapy also 
predisposes to infection and disease (Sarasombath, et al., 1987). The 
relative importance of change in intestinal flora, motility, pH, is 
unknown and remains under scrutiny. The pathogenesis of enteric fever 
has been extensively studied. The site at which S. typhi penetrates the 
intestinal barrier in man has not been defined with certainty. Jejunal 
biopsy from infected humans revealed inflammation, suggesting the 
possibility that the jejunum would be the site of penetration in some 
patients (Youmans, et al., 1986).                    
Many studies have been directed to the cause of prolonged fever 
and toxic symptoms of enteric fever. For years, circulating endotoxins 
and lipopolysaccharides, the components of the bacterial cell wall, were 
implicated. Injections of an endotoxin into healthy volunteers produced 
symptoms of the disease: headache, fever, abdominal pain, and malaise, 
and moreover laboratory findings (anaemia, leucopenia) remarkably 
similar to findings in the same volunteers during actual S. typhi 
infections (Mandell, et al., 1985).   
 
 
2.13  Clinical manifestations of enteric fever: 
The clinical course may vary from mild undifferentiated pyrexia to 
a rapidly fatal fulminating disease. The onset is usually gradual, with 
headache, malaise, anorexia, a coated tongue and abdominal discomfort 
with either constipation or diarrhoea. The typical features are step-ladder 
pyrexia, with toxaemia. Hepatomegaly is also common. Rose spots 
appear on the skin during the second or third weak of enteric fever 
(MacSween and Whaley, 1992). 
2.14  Diagnosis of enteric fever: 
2.14.1 Widal test:  
 Detection of anti S. typhi antibodies in patients is a useful 
diagnostic aid. Amongst the various methods developed over the years 
for this purpose the Widal test, based on bacterial agglutination, has 
remained the most widely used, even though it is neither specific nor 
sensitive. It is popularly used due to the fact that it is simple to use and 
inexpensive (Lim, et el, 1998).     
    This test for the serological diagnosis of enteric fever was much 
used in the past when effective selective media were not available and it 
was more difficult to isolate the causal, Salmonella species, from the 
patient’s blood or faeces (Collee, et al., 1996). In developing countries, 
where typhoid fever is endemic and where there are few microbiology 
laboratories to provide diagnosis by culture, the search continues forth 
for non-cultural techniques that provide rapid and reliable diagnosis 
(Jesudason, et al., 1998).   
2.14.2 Interpretation of Widal test results: 
 The value of Widal test in diagnosing enteric fever in endemic 
areas remains controversial. Some express the view that the test lacks 
standardization and adequate sensitivity to be clinically useful, while 
others consider the test to have a diagnostic value when judged in 
association with clinical findings and knowledge of the normal O and H 
agglutinins titre in local population. Of shared concern, however, is now 
necessary to avoid misuse and misinterpretation of Widal test 
(Cheesbrough, 2000). In typhoid fever the H titre is elevated earlier and 
more frequently than the O titre and antibodies rise during the second 
week of illness. It appears that H titre is more useful than O titre. 
Antibiotic treatment did not affect the rise of antibody titre in typhoid 
fever (Abraham, et al., 1981). In Sudan, a titre of 1:160 or more for O 
somatic antigen is considered as evidence of typhoid fever (Elfaki, 
1987).      
 The features significantly associated with a final diagnosis of 
typhoid fever were: pre-admission duration of fever (longer than or =7 
days), Hepatomegaly, leucopenia due to absolute neutropenia with 
relative lymphocytosis, although the sensitivity, specificity and 
predictive value of any of these features can not be used reliably to 
distinguish typhoid fever from other non typhoidal febrile illnesses 
(Khan, et al., 1998).   
2.14.3 Misguiding O and H titres: 
 The registration of O and H titres can often indicate previous 
Salmonella infections, chronic salmonellosis associated with 
schistosomal infection, vaccination with typhoid vaccine, current 
infection with other than Salmonella species, chronic liver disease 
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associated with raised globulin levels and disorders such as rheumatoid 
arthritis, rheumatic fever, multiple myeloma or a nephritic syndrome 
besides ulcerative colitis (Johnson, et al., 1996).      
2.15 Toxin production:  
All members of the family enterobacteriacae possess an 
endotoxin. This toxin is responsible for endotoxic shock in Gram-
negative bacterial septicaemia (Ochei and Kolhatkar, 2000). Salmonella 
typhi contains gluc-lipo-protein complexes. The endotoxin is obtained by 
extracting the bacterial emulsion with trichloroacetic acid. This 
endotoxin is thermo stable; survives at a temperature of 120 C for 30 
minutes, and is characterized by a highly specific precipitin reaction and 
pronounced toxic and antigenic properties. Investigations have shown 
the presence of exotoxic substances in S. typhi, which are inactivated by 
light, air and heat (80 C), as well as enterotropic toxin phosphatase and 
pyrogenic substances (Pyatkin and Krivochein, 1987).                 
2.16 Immunity: 
 Infections with S. typhi or paratyphi usually confer a certain 
degree of immunity. Reinfections may occur but are often milder than 
the first infection. Circulatory antibodies to O and Vi antigens are related 
to resistance to infection and disease. However, relapses may occur in 2-
3 weeks after recovery in spite of the antibodies. Secretory IgA (SIgA) 
antibodies may prevent attachment of Salmonella to intestinal epithelium 
(Brooks, et al., 1998). It can persist in the gut for about 48 weeks. Thus, 
the immunities as a whole can persist beyond one year after the onset of 
illness, unless there are persistent booster stimulation S. typhi bacilli that 
exist in the environment, where, then, the immunities may be lifelong 
(Sarasombath, et al., 1989). The microorganism is an example of 
facultative intracellular parasite, surviving well within macrophages and 
requiring cell-mediated immunity for control (Youmans et al., 1986). 
After the onset of illness, the cell-mediated immunity persists for 16 
weeks (Sarasombath, et al., 1987).   
Immunity acquired after typhoid fever and paratyphoids is 
relatively stable but relapses and reinfections sometimes occur. 
Antibiotics, used as therapeutic agents, inhibit the immunogenic activity 
toward the pathogens, which change rapidly and lose their O and Vi 
antigens (Pyatkin and Krivochein, 1987). 
2.16.1 Antibodies in enteric fever: 
Salmonella causing enteric fever stimulates the formation of three 
types of agglutinins, which are of use in diagnosis. They are H, O and 
Vi. The H antibody, which is produced in response to stimulation by 
flagellar antigens, appears towards the end of the first week of the 
disease, and usually reaches the highest titre. It persists longer than the 
others after recovery, sometimes for many years, and its formation may 
again be stimulated, non-specifically, in subsequent febrile illnesses. 
Agglutination is rapid and the agglutinated bacilli form large 
fluffy clumps. There is no evidence that H antibody is protective or helps 
to combat the disease (Stokes and Ridgway, 1983; Stokes, Ridgway and 
Wren, 1993). 
 Formation of O antibody is stimulated by O somatic antigens. It 
also appears in the first week of illness and seldom rises above a titre of 
about 1:640 (Curtis, Edwards A, Kapil A 1983; Stokes, et al., 1993). 
Anti O polysaccharide chain antibody titres are lower at the first week 
and increase up to the third week of the infection (Mastroianni, et al., 
1989). 
 After recovery the titre falls and it is seldom demonstrable a year 
later. Production is not easily stimulated, non-specifically, in subsequent 
illnesses. Agglutination occurs more slowly and the clumps of the bacilli 
are small and dense (Stokes and Ridgway, 1983). 
After the onset of illness, immunoglobulins; IgG, IgM, anti O and 
H agglutinins persist for two years, 16 weeks, 16 weeks and 36 weeks 
respectively (Sarasombath, et al., 1987).        
The Vi antigen, also, a somatic antigen, is possessed by 
Salmonella typhi, S. paratyphi C and other coliforms, including certain 
strains of E. coli. Typhoid and paratyphoid bacilli, which possess large 
quantities of this antigen often, give rise to severe disease (Stokes et al., 
1993). 
Occasionally, only Vi antibody can be investigated but that can 
happen in rare cases, However, in most cases there is no need to perform 
the Vi agglutination test. The antibody is probably of value in combating 
infections of Vi strains.  
In the majority of patients H and O agglutinins can be easily 
demonstrated. Occasionally only one of the agglutinins is found, and 
very occasionally no specific antibody is demonstrable in enteric fever 
(Stokes and Ridgway, 1983; Stokes, et al., 1993). 
2.17 Complications of typhoid fever: 
Complication to typhoid fever that can be classified as secondary 
to toxaemia are myocarditis, hyperpyrexia, hepatic and bone marrow 
damage and those secondary to local gastrointestinal lesions are 
haemorrhage and perforation (Mandell, et al., 1985). Some degree of 
bronchitis or bronchopneumonia is frequently found. Some develop 
psychosis, abscesses, nephritis, haemolytic anaemia, venous thrombosis 
and peripheral neuritis beside other complications. Nephritis was 
reported during typhoid fever in patients, who had previous 
Schistosomiasis mansoni infections in Gezira irrigated scheme, Sudan 
(Musa, Saleh, Abu Asha 1981). It is also known that a chronic form of 
salmonellosis can exist in patients with schitosomaisis as reported from a 
study in Brazil (Hagashi, et al., 1975; Saleh et al 1975).    Osteomyelitis 
is a rare sequel (Ananthanarayan and Paniker, 1997). 
Fatalities still occur occasionally, probably in less than 1% of the 
patients receiving appropriate antimicrobial and supportive therapy 
(Mandell, et al., 1985). 
2.17.1 Relapses: 
Relapses, a recurrence of manifestation of typhoid after initial 
clinical response, occur in about 8-12% of patients who have not 
received antimicrobial therapy. Antimicrobial therapy may increase the 
rate of relapse occurrence. In several studies, the relapse rate was found 
to be doubled in patients receiving chloramphenicol therapy for 2 weeks. 
Ampicillin probably does not affect the rate of relapse. Studies of 
patients given trimethoprim-sulphamethoxole (co-trimoxazole), indicate 
that the rate of relapse may be relatively less than the patients treated 
with chloramphenicol (Pyatkin and Krivochein, 1987). 
Convalescence is slow; in about 5-10% of cases, relapses occur 
during convalescence. The relapse rate is higher in patients treated with 
chloramphenicol (15-20%) (Ananthanarayan and Paniker, 1997). 
2.18 Epidemiology: 
 In the vast majority of cases, human beings acquire Salmonella by 
the ingestion of contaminated food or water. Direct faecal-oral spread 
can occur, particularly in children. Transmission by the airborne route is 
thought to occur rarely (Cheesbrough, 2000).   
A few Salmonella serotypes are highly host adapted and tend to be 
virtually “species specific”. For example, the only known reservoir for S. 
typhi is man, and infection with the organism strongly implies direct or 
indirect exposure to a human source (Mandell, et al., 1985).     
Typhoid fever has been virtually eliminated from the advanced 
countries during the last several decades mainly as a result of 
improvements in water supply and sanitation but it continues to be 
endemic in the poor nations of the world (Thong et al., 1998). It is 
endemic in developing countries, in Africa, South Central America and 
the Indian subcontinent. By contrast, in developed countries incidence is 
much lower (Threlfall and Ward, 2001). The control of paratyphoid 
fever has not been successful. The distribution of paratyphoid bacilli 
shows marked geographical differences. S. paratyphi A is prevalent in 
India and other Asian countries, Eastern Europe and South America, S. 
paratyphi B in Western Europe, Britain and north America; and S. 
paratyphi C in eastern Europe and Guyana (Rowe, et al , 1997). 
Carriers occur with paratyphoid bacilli also. While S. paratyphi A 
occurs in human beings, S. paratyphi B can infect animals such as dogs 
or cows, which may act as sources of human disease (Cheesbrough, 
2000). Typhoid occurs into two epidemiological types. The first is 
endemic residual typhoid that occurs through the year, though seasonal 
variation may sometimes be apparent. The second is epidemic typhoid, 
which may occur in endemic or non-endemic areas irrespective of season 
(Johnson, et al., 1996).  
       Typhoid epidemics are water, milk or food-borne. Water-borne 
epidemics, once so common, have become rare due to better control of 
drinking water. Milk-borne epidemics also have become more rare due 
to the general application of pasteurization. Food-borne outbreaks may 
be due to contamination of tinned stuffs, vegetable or shellfish which are 
eaten raw or uncooked (Rowe, et al., 1997).  
 
2.18.1 Salmonella enterica serotype typhi outbreaks: 
       After extensive outbreaks of typhoid fever caused by S. enterica 
serotype typhi which occurred in Mexico in the early and mid 1970s, it 
was reported that epidemic strains were resistant to chloramphenicol 
(Anderson and Smith, 1972; Paniker and Vilma, 1972). 
2.18.2 Salmonella paratyphi A outbreaks: 
        Outbreaks of enteric fever associated with S. paratyphi A have 
rarely been reported in India (Thong, et al., 1998; Sood, et al., 1999). In 
1998, the incidence of enteric fever, caused by drug-resistant S. 
paratyphi A, abruptly increased in the New Delhi region. In the first 6 
months of treatment in 1999, 32% of isolates were found resistant to 
both chloramphenicol and co-trimoxazole and another 13% resistant to 
more than two other antibiotics. Salmonella paratyphi A, which caused 1 
to 15% of the enteric fever cases in India, has been increasing since 1996 
(Sood, et al., 1999). The studies proved that some of the isolates from 
the New Delhi region had a decreased susceptibility to ciprofloxacin, the 
drug of choice for enteric fever in India (Chandel, et al., 2000) 
 
 
2.18.3 Salmonella paratyphi B outbreaks: 
Incidence of Salmonella paratyphi B has generally increased since 
1998; the spike in S. paratyphi B in the third and fourth quarters of 1999 
can be attributed to an outbreak in British Columbia, Alberta, and 
Saskatchewan caused by contaminated alfalfa sprouts (Stratton, et al., 
2001). In addition to this large outbreak, additional outbreaks were 
reported between 1998 and 2002. However each out break was small, 
and most involved fewer than six patients (Mulvey, et al., 2004). 
Antimicrobial susceptibility testing was performed on all strains by using 
the disk-diffusion method as described by the National Committee for 
Clinical Laboratories Standards (NCCLS). Susceptibilities were 
determined for ampicillin (A), chloramphenicol (C), ciprofloxacin (Cp), 
streptomycin (S), sulfamethoxazole (Su), tetracycline (T), and 
trimethoprim(Tm). Some isolates displayed resistance to five commonly 
used antibiotics (ACSSu and T) (Mulvey, et al., 2004). The emergence 
of multi-resistant S. paratyphi B was documented recently in 
Netherlands and Scotland (van Pelt, et al., 2003; Brown, et al., 2003).     
2.18.4 Chronic carrier state:  
   Enteric fever occurs at all ages but is probably most common in 
the 5-20 year age group. The age incidence is related to the endemicity 
of the disease and the level of sanitation (Cheesbrough, 2000). The 
faeces of persons who have unsuspected subclinical disease or are 
carriers are more important as a source of contamination than those of 
frank clinical cases that are promptly isolated; e.g. when carriers work as 
food handlers they are “shedding“ the organism (Brooks, et al., 1998). 
The source of infection, a patient, or far more frequently, a carrier 
patient, who continues to shed typhoid bacilli in faeces weeks to three 
months after clinical cure is called a “convalescent carrier“. Those who 
shed the bacilli for more than three months but less than a year are called 
“temporary carriers” and those who shed the bacilli for over a year are 
called “chronic carriers”. In other words, persons who continue to 
excrete organisms more than a year after initial discovery of organisms 
in stool are designated chronic carriers (Mandell, et al., 1985). 
The development of the carrier state is more common in women 
and in the older age groups (over 40 years). Some persons may become 
carriers, following a past infection, symptomless excretors. The shedding 
of the bacilli is usually intermittent in this case (Paniker and Vilma, 
1997). 
Food handlers or cooks who become carriers are particularly 
dangerous. The best known of such typhoid carriers was Mary Mallon 
(Typhoid Mary), a New York cook who, over a period of 15 years, 
caused at least seven outbreaks affecting over 200 persons,(Curtis, et al 
1983). 
 Despite recovery from the acute phase of the disease, some 
individuals continue to excrete the organism in the faeces or less often in 
urine (MacSween and Whaley, 1992). Excretion of organisms in stool 
after enteric fever persists for variable periods of time, usually a few 
weeks. The incidence of chronic enteric carrier state after typhoid fever 
is 1-3% (Mandell, et al., 1985; Johnson, et al., 1996). The organism is 
retained in the gallbladder and biliary passages (Johnson, et al., 1996). 
Chronic foci of infection in biliary tract of carriers may be related, in 
part, to intracellular persistence of microorganisms in macrophages 
(Youmans, et al., 1986). 
Incidence of development of chronic enteric carrier state after 
typhoid fever increases with age (Mandell, et al., 1985). In most cases 
the carrier state is due to persistence of gallbladder infections. Typhoid 
cholecystitis is probably initiated during the bacterimic phase, and 
represents the reservoir from which all cases are directly or indirectly 
acquired (MacSween and Whaley, 1992). In most carriers, the organism 
persists in the gallbladder, particularly if gallstones are present, and in 
the biliary tract (Brooks, et al., 1998).  
Patients with Schistosoma haematobium involvement, in the 
urinary tract, have a propensity to become chronic urinary carriers after 
infection. Urinary carriers may continue to excrete large numbers of 
bacilli in urine for months or a year (Mandell, et al., 1985). 
 In schistosomiasis endemic areas there are high incidences of 
chronic S. typhi and S. paratyphi infections and carriers. Salmonella 
colonises adult Schistosoma flukes and are  protected from antibiotics 
(Cheesbrough, 2000). 
Prolonged or recurrent typhoid fever is usually regarded as minor 
or even episodes of salmonelluria are not uncommon in patients infected 
with Schistosoma species. In such cases Salmonella infection is often 
apparently resistant to antibiotic therapy. Schistosoma–Salmonella 
interactions have been described with all species of Schistosoma, notably 
S. haematobium, S. mansoni, S. intercalatum and S. japonicum. The 
adult worms of Schistosoma live in the mesenteric venous plexuses; 
Salmonellae electively stick onto the outer wall of adult Schistosomas. 
As a result of this, Salmonella septicaemia is facilitated and sustained by 
schistosomal infestation, and several varieties of Salmonella may be 
involved. These Salmonella infections can not be cured without the 
treatment of the associated schistosomiasis (Gendrel, 1993). 
A study of 150 files and records of patients suffering from typhoid 
or paratyphoid fever, in Libreville, revealed that the incidence rates of 
salmonellosis associated with schistosomiasis constituted 13% whilst 
with nematodiasis 2.3%, with sickle cell anaemia 7% and with HIV 
infection 8% (Okome, et al., 2000).                   
2.18.5 Diagnosis of carriers: 
     The Widal reaction is of no value in the detection of carriers 
in endemic countries. The identification of faecal carriers is by isolation 
of the bacillus from faeces or from bile (Mandell, et al., 1985). Culture 
of bile obtained by duodenal aspiration is usually positive and may be 
employed for the detection of carrier. The tracing of carriers in cities 
may be accomplished by screening food handlers and cooks. Testing for 
the presence of antibody to the Vi antigen has been suggested as a 
mechanism for screening for typhoid carriers (Rowe et al., 1997). 
2.18.6 Treatment of chronic carriers:                       
While antimicrobial therapy has been so effective in the treatment 
of cases, it has been disappointing in the treatment of carriers. A 
combination of antimicrobial therapy along with a vaccine have been 
tried for the eradication of carrier state. Some chronic carriers have been 
cured by ampicillin alone (Brooks, et al., 1998). Elimination of the 
carrier state may require heroic measures such as cholecystectomy, 
pyeloithoctomy or nephrectomy (Johnson, et al., 1996).  
 
2.19 Management of enteric fever:  
2.19.1 Therapeutic approach to patients with enteric fever: 
Specific antimicrobial therapy for enteric fever became available 
only in 1948 with the introduction of chloramphenicol (Rowe, et al., 
1997). Many strains are sensitive to chloramphenicol, ampicillin, 
gentamicin, tetracycline, co-trimoxazole and some other antibiotics 
(Threlfall, Rowe and Ward, 1992). Chloramphenicol was considered to 
be the most effective agent for the treatment of typhoid fever; an 
alternative drug was co-trimoxazole (Mandell, et al., 1985; Collee, et al., 
1996). Chloramphenicol was the fist line of choice and in developed 
countries its use resulted in a reduction in mortality rates. Ampicillin not 
chloramphenicol may terminate the chronic carrier state and is preferred 
in intravascular infection. Trimethoprim-sulfamethoxazole (co-
trimoxazole) is especially useful in Salmonella infections caused by 
organisms resistant to both chloramphenicol and ampicillin (Mandell, et 
al., 1985). Ciprofloxacin should be considered as the drug of choice for 
treatment of typhoid fever in patients likely to have acquired infection in 
areas reporting multi resistant strains (Collee, et al., 1996). All strains 
with decreased sensitivity to ciprofloxacin were also resistant to nalidixic 
acid (Threlfall and Ward, 2001). It is necessary to test antibiotic 
sensitivities of any strain isolated from a septicaemic illness (Collee, et 
al., 1996). Though S. typhi is susceptible, in vitro, to many antibiotics 
such as streptomycin and tetracycline, these drugs are ineffective in vivo, 
(Johnson, et al., 1996). 
2.20 Complications of antimicrobial therapy: 
Antimicrobial therapy may lead to complications in patients with 
typhoid fever. The rare idiosyncratic reaction to chloramphenicol, 
characterized by severe aplastic anaemia, occurs in about 1of 25,000 
persons treated with this antibiotic. Ampicillin and amoxicillin produce 
rashes and hypersensitivity reactions, and trimethoprim-sulphamexazole 
(co-trimoxazole), may cause bone marrow suppression and abnormalities 
in hepatic function. Toxic crisis in patients with typhoid are exacerbation 
of symptoms of toxaemia temporally related to administration of 
antibiotics. These reactions have been attributed to sudden release of 
endotoxin and considered analogous to the Jarish-Herxheimer reaction 
seen in patients with syphilis treated with penicillin. The relationship of 
these “reactions” to antimicrobial therapy is by no means clearly 
established (Thong, et al., 1998).  
2.21 Drug resistance: 
 In persons receiving antimicrobial drugs orally for several days, 
parts of the normal intestinal flora may be suppressed. Drug-resistant 
organisms may establish themselves in the bowel in great numbers and 
may precipitate serious enterocolitis (Brooks, et al., 1998). Resistance to 
individual drugs depends on serotype, phage type, and country of origin 
of Salmonella, (Threlfall, Rowe and Ward, 1991). 
Though occasional strains had been identified in the laboratory, 
resistance to chloramphenicol did not pose any problem in typhoid fever 
till 1972, when resistant strains emerged in Kerala (India), where theses 
strains became endemic. Subsequently such strains carrying drug 
resistant plasmids appeared in many other parts of India 
(Ananthanarayan and Paniker, 1997). Alternative drugs for typhoid fever 
are ampicillin and trimethoprim. However, following outbreaks in the 
Indian subcontinent, the Arabian Gulf, the Philippines, in the late 1980s 
and early 1990s, causative strains were found to be  resistant to 
ampicillin and trimethoprim in addition chloramphenicol. The efficacy 
of these antimicrobials has also been impaired (Threlfall and Ward, 
2001). Trimethoprim-sulfamethoxazole (co-trimoxazole), has been used 
in recent years in the treatment of enteric fever. Reports of efficacy have 
varied from claims of equivalence to chloramphenicol to unsatisfactory 
bacteriologic response. These variations in results have been attributed to 
the administration of insufficient doses of drugs and differences in 
strains of S. typhi, and variation in immunity in different geographical 
areas (Mandell, et al., 1985). During 1996-97, isolates uniformly 
susceptible to all antibiotics, including ciprofloxacin and ceftriaxone 
were commonly used in the treatment of enteric fever. However, in 1998 
the incidence of enteric fever caused by drug resistant S. paratyphi A, 
abruptly increased, and a number of drug resistant isolates susceptible to 
ciprofloxacin markedly decreased (Chandel, et al., 2000). 
2.21.1 R plasmids: 
Most wild antibiotic–resistant bacteria are not chromosomal 
mutants but carry the resistant genes in plasmids (R plasmids) and 
mechanism of resistance is usually quite distinct from that of 
chromosomal mutants resistant to the same antibiotic (Bull and Meadow, 
1978). In all multidrug–resistant (MDR) strains of typhoid bacilli, so far 
examined, multiple resistance has been encoded by plasmids of the H1 
incompatibility group (Rowe, et al., 1997). 
  These plasmids cause considerable medical and veterinary 
problems because many of them are conjugative and can be transferred, 
particularly between different genera of enterobacteria. Beside many of 
them specify resistance to more than one drug, and in some cases to as 
many as six or seven unrelated drugs (Bull and Meadow, 1978).  
 
2.21.2 Biochemical mechanism of plasmid-coded resistance:  
R plasmids coding for resistance to, virtually, all the clinically 
used antimicrobial drugs have been described. The biochemical means 
by which the resistance is achieved differs from one drug to another, but 
for any particular drug the mechanism appears almost universal, 
irrespective of the organism, from which the plasmids are isolated. 
Resistance to chloramphenicol is the result of plasmid-coded enzymes, 
which chemically modify the antibiotic to a non-toxic form (Bull and 
Meadow, 1978). The R plasmid coding for chloramphenicol resistance, 
also, codes for sulphonamide resistance; therefore only the trimethoprim 
portion of the drug is active against multiple resistant strains (Thong, et 
al., 1998).  
  
 
 
 
 
 
 
CHAPTER THREE 
3. Materials and Methods  
3.1 Materials: 
3.1.1Culture Media: 
Different types of culture media including solid, semi-solid, and 
liquid media were used to identify the aerobic bacteria. All culture media 
were prepared according to the methods described by the manufacturer. 
3.1.1.1 Solid Media: 
3.1.1.1.1 Brilliant green bismuth sulphite agar (modified Wilson & 
Blair’s medium) (Code CM 329): 
Oxoid Ltd supplied this medium. It consisted of peptone (Oxoid L 
37), dextrose, disodium phosphate, ferrous sulphate, bismuth sulphite 
indicator, brilliant green and agar No3 (Oxoid L13). Four grams of the 
medium were dissolved completely by boiling in 100 ml of distilled water. 
The pH was adjusted to 7.7, then was sterilized by boiling only without 
autoclaving. The medium was cooled to 55C and distributed into sterile 
petri dishes in 25 ml volumes (thick plates). 
3.1.1.1.2 Salmonella Shigella Agar (SSA) (code CM108): 
Oxoid Ltd., England supplied this medium. It consisted of peptone, 
lactose, bile salts, sodium citrate, sodium thiosulphate, ferric citrate, 
brilliant green, neutral red, and agar. Sixty-three grams of the medium were 
dissolved in one litre of distilled water by boiling. The pH was adjusted 
to7.0, cooled to 55C and distributed aseptically without sterilization 
(according to the manufacturer) into sterile petri dishes, 20 ml in each dish.     
3.1.1.1.3 MacConkey Agar (Code CM 47): 
Oxoid Ltd., England supplied this medium. Fifty-two grams of the 
powder were dissolved in 1 litre of distilled water by boiling. The pH was 
adjusted to 7.4, then the medium was sterilized by autoclaving (121C for 15 
minutes), and cooled to 50 C, then distributed into sterile petri dishes 20 ml 
each. 
3.1.1.1.4 Nutrient Agar: 
Plasmatic Ltd., UK, supplied the medium. It was prepared according 
to the manufacturer by dissolving 28g in 1 liter distilled water, the pH was 
adjusted to 7.4, then was sterilized by autoclaving (121C for 15 minutes), 
cooled to 50-55C and then distributed into sterile petri dishes, 20 ml each. 
3.1.3.1.5 Christensen’s Urea Agar:  
Plasmatic Ltd., UK supplied this medium. It was prepared by 
dissolving 2.4 g of the powder in 95 ml of distilled water by boiling. The 
pH was adjusted to 6.8, then the medium was autoclaved at 121C for 15 
minutes. The base medium was cooled to 50C and aseptically 5 ml of 
sterile 40% urea solution were added. And the medium was distributed into 
screw-capped bottles 10 ml each, and then allowed to set in the slope 
position. 
 3.1.1.1.5 Kligler Iron Agar (KIA):  
Plasmatic Ltd., UK supplied this medium. According to the 
manufacturer, 38.5 g of the powder was dissolved in 1 liter of distilled 
water by boiling. Then the medium was distributed into test tubes 5 ml 
each. The tubes were sterilized by autoclaving (121C for 15 minutes), 
cooled and positioned to give a butt and slant in each tube. 
3.1.1.1.6 Simmons’s Citrate Medium:  
Plasmatic Ltd., UK supplied this medium. According to the 
manufacturer, 30 g of the powder were dissolved in 1 liter of distilled water 
by heating. The medium was distributed into clean test tubes 5 ml each. 
The tubes were sterilized by autoclaving (121C for 15 minutes), then 
cooled and kept for the citrate utilization test. 
3.1.1.1.7 Diagnostic Sensitivity Test (DST) Agar (Code CM 261): 
Oxoid Ltd. supplied this medium. The medium was prepared by dissolving 
40 g in 1 liter of distilled water by boiling. The pH was adjusted to 7.4. 
Sterilization was done by autoclaving (121C for 15 minutes). Then, cooled 
to 50C and enriched by bovine or sheep blood to enhance the growth of 
fastidious organisms. Then the medium was distributed into sterile petri 
dishes 20 ml each.  
 
3.1.1.1.8 Brain Heart Infusion Agar (Code CM 275): 
Oxoid Ltd. supplied this medium. It was prepared by dissolving 45 g 
in 1 liter distilled water by heating. The medium was distributed into clean 
bottles 10 ml each, the bottles were sterilized by autoclaving (121C for 15 
minutes), then cooled to 50 C and positioned to give slant media. The 
medium was used for the storage of the isolated bacteria. 
3.1.1.2 Semi-solid Media: 
It used for motility testing. Thirteen grams of the dehydrated nutrient 
broth were added to 4g of Oxoid agar No. 1 and dissolved in 1 litre of 
distilled water to give semi-solid medium. The pH was adjusted to 7.4, and 
then the medium was distributed into clean test tubes 5 ml each. The tubes 
were sterilized by autoclaving (121 C for 15 minutes), then cooled to ready 
for motility test. 
3.1.1.3 Liquid Media: 
 3.1.1.3.1 Selenite-F-broth (Code CM 395): 
Oxoid Ltd supplied this medium. It consisted of peptone, lactose, and 
sodium phosphate. Nineteen grams of the medium were dissolved in one 
litre of distilled water to which 4g of sodium biselenite (Oxoid L 121), was 
added. The medium was sterilized by boiling for 10 minutes, mixed well 
and filled into containers to depth 5 cm.   
  
3.1.1.3.2 Nutrient Broth:  
Plasmatic Ltd. supplied this medium. It was prepared by dissolving 
13 g of the powder in 1 litre of distilled water. The medium was distributed 
into clean test tubes, and then tubes were autoclaved at 121C for 15 
minutes. The tubes were then cooled. 
3.1.1.3.3 Peptone Water:  
Plasmatic Ltd. supplied this medium. It was prepared by dissolving 
15 g of the powder in 1 liter of distilled water by shaking or rotation. The 
pH was adjusted to 7.4, and then the medium was distributed into clean test 
tubes 5 ml each. The tubes were sterilized by autoclaving (121C for 15 
minutes) and cooled. 
3.1.1.3.4 Peptone water sugar: 
The medium was prepared according to Ochei and Kolhatkar (2000). 
Ninety ml of peptone water was prepared and the pH was adjusted to 7.1. 
Ten ml of Andrade’s indicator were added. The medium was distributed 
into test tubes with sterile Durham’s tubes inside each tube, in 5 ml volume 
for each tube. The tubes were autoclaved at 121C for 15 minutes. Sugar 
solutions were prepared by dissolving 10 g of the appropriate sugar in 100 
ml of distilled water. The sugar solutions in the volume of 0.25 ml were 
dispensed into each tube aseptically. The carbohydrates used in this test 
were glucose, lactose, sucrose, maltose and mannitol. 
3.1.1.3.5 Glucose phosphate peptone broth: 
The medium was prepared according to Barrow and Feltham (1993). 
Five grams of peptone, 5g of potassium phosphate were added to 1 litre of 
distilled water and steamed until the solids were dissolved. The pH was 
adjusted to 7.5, and then 5g of glucose were added and mixed. The medium 
was distributed into test tubes 5 ml each and sterilized by autoclaving at 
115C for 10 minutes. 
3.1.1.3.6 Nitrate Broth: 
This medium contained 1g of potassium nitrate; it was prepared 
according to Barrow and Feltham (1993), by dissolving the nitrate in 1 litre 
of nutrient broth, distributed into test tubes and then sterilized by 
autoclaving at 121 C for 15 minutes. 
3.1.1.3.7 Brilliant green bile (2%) broth (Code CM 31): 
Oxoid supplied this medium. It consisted of peptone, lactose, Ox-
Bile (purified) and brilliant green. Forty grams of the medium were 
dissolved in one litre of distilled water. It was mixed well, and distributed 
into containers. Then it was sterilized by autoclaving at 121 C for 15 
minutes. 
3.1.1.4 Brilliant green bile diphasic medium (Code CM 31): 
Brilliant green bile diphasic medium (Castañeda form) consisted of 
brilliant green bile broth and a slope of brilliant green bile agar. 
 3.1.1.4.1 Brilliant green bile agar (Code CM 263): 
It was obtained by adding 1.5 g of agar to brilliant green bile broth 
and was dispensed in 25 ml amounts in medical bottles (200 ml), flat type 
fitted with screw-caps that had a central hole and rubber liner. It was 
sterilized by autoclaving at 121 C for 15 minutes. Then allowed to cool in a 
horizontal position to give an agar slope along one side. 
3.1.1.4.2 Brilliant green bile broth(Code CM 31): 
Twenty five ml of brilliant green bile broth were dispensed 
aseptically in each bottle containing an agar slope. Each bottle was covered 
with a foil cap. The bottles were stored in an upright position in a dark cool 
place.     
3.1.2 Chemicals and Reagents: 
All reagents were kept in well-closed glass stoppered bottles and 
protected from direct sun light. 
3.1.2.1 Gram’s solutions (The British Drug Houses): The reagents were 
prepared according to Ochei and Kolhatkar (2000): 
3.1.2.1.1 Crystal violet: Crystal violet powder was dissolved in distilled 
water to give 1% concentration. 
3.1.2.1.2 Lugol’s Iodine: This was prepared by dissolving 20 grams 
potassium iodide in 50 ml distilled water and then dissolving 10 grams 
iodine by shaking and make up the volume to 1000 ml. 
3.1.2.1.3 Decolourizing Reagent: This was prepared by mixture 1:1 of 
ethyl alcohol and acetone. 
3.1.2.1.4 Counter Stain: This was prepared by dissolving 0.5 grams 
Safranin in 100 ml distilled water. Also was prepared by diluting strong 
Carbol fuchsin (1:10) distilled water. 
3.1.2.2 Andrade’s Indicator: This was prepared according to Ochei and 
Kolhatkar (2000) by dissolving 5 grams of acid fuchsin in one litre of 
distilled water and 150 ml alkali solution (NaOH) was added. It was used 
in peptone water sugar medium. 
3.1.2.3 Methyl red solution: This solution was prepared as described by 
Barrow and Feltham (1993) by dissolving 0.04 grams of methyl red powder 
in 40 ml of ethanol and the volume was diluted with distilled water to 100 
ml. It was used in methyl red test. 
3.1.2.4 Voges-Proskauer (V.P) test reagent: This reagent was composed 
of 40% potassium hydroxide (KOH) and 5% alpha-naphthol in absolute 
ethanol. 
3.1.2.5 Nitrate test reagent: This reagent was composed of two solutions: 
Solution A: Sulphanilic acid 0.33% in 5 N-acetic acid dissolved by gentle 
heat. 
Solution B: Dimethyl-alphanaphthylamine 0.6% in 5 N-acetic acid. The 
complete reagent was used in nitrate test. 
3.1.2.6 Oxidase reagent: The reagent is not stable. It was therefore 
prepared immediately before use. It was prepared by dissolving 0.1 grams 
tetramethyl-p-phenylene diamine dihydrochloride in 10 ml distilled water 
(Cheesbrough, 2000). 
3.1.2.7 Physiological saline: It was prepared according to Ochei and 
Kolhatkar (2000) by dissolving 9 grams of sodium chloride in 1 litre 
distilled water. 
3.1.2.8 Kovac’s reagent:  
It was prepared according to Barrow and Feltham (1993) by 
dissolving 5 grams of para-dimethylaminobenzaldehyde in 75 ml amyl 
alcohol by gentle warming in a water bath, about 50-55 C. Then cooled and 
added to 25 ml concentrated HCL. Protected from direct sun light and 
stored at 4 C. 
3.1.3 Biological Materials: 
Bovine Blood or Sheep Blood (defibrinated blood), was used for the 
enrichment of media. They were obtained fresh and free from 
anticoagulants and antimicrobial agents. 
3.1.4 Antibiotic Discs: 
Plasmatic Ltd., UK supplied all antibiotic discs used in the test of 
antibiotic susceptibility test. The antibiotics used were ciprofloxacin (5 µg), 
chloramphenicol (30 µg), trimethoprim (10 µg), ampicillin (10 µg), 
nalidixic acid (10 µg) and co-trimoxazole (25 µg). 
3.1.5 Test Control Organisms: 
Organisms from American Type of Culture Collection (ATCC) 
(USA), and National Collection of Type Culture (NCTC) (UK), were used 
as test control organisms. They were Salmonella typhi (ATCC St. 19430), 
and Salmonella paratyphi B (NCTC). 
3.1.6 API System: 
API-20E Test kits for the identification of enteric bacteria were used 
to confirm the isolated bacteria. BioMerieux, Inc. Hazelwood, MO., 
France, supplied the kits. 
3.2 Methods: 
3.2.1 Sterilization and disinfectants: 
The glassware (Petri dishes, Pipettes, test tubes, flasks, etc.), was 
sterilized in the hot air oven at 160 C for 1 hour 
Media and solutions were sterilized by autoclaving at 15 pounds per 
square inch (psi) for 15 minutes at 121C. Carbohydrate media were 
sterilized by autoclaving at 110 C for 10 minutes. 
Formalin of concentration 40% was used for sterilizing the room 
media. 
Inoculating wire loops, needles and points of forceps were sterilized 
by direct flame. 
Phenolic disinfectant was used for disinfecting floor, walls, and the 
roof of the laboratory. Alcohol (70%)(v/v), was used for disinfecting the 
benches. 
3.2.2 The site of study: 
El-rahad Irrigated Scheme, Gadarif State – Eastern Sudan, was 
chosen as the site for the present study. El-fao town comprises sporadically 
scattered villages and hamlets that rely largely on subsistence agriculture. 
The relatively close proximity of this town to Gadarif town provides 
practical advantages for epidemiologic and laboratory support.  
3.2.3 Study Design: 
A retrospective study was carried out in Gadarif State, Sudan 
(Gadarif town, El-hawata town, and El-fao town). The period of the study 
was from December 2004 to June 2005. The targeted population were the 
patients already diagnosed as suffering from typhoid fever.  
3.2.3.1 Sample size: - 
Seventy-one specimens were collected from patients, already 
diagnosed as suffering from typhoid fever with  significant titres of 1/320 
or more. Twenty of these had significant titre to S.typhi, 29   S.paratyphi B 
and 22 to both S.typhi and S.paratyphi B. 
 
 
 3.2.3.2 Specimen Collection: 
The questionnaire included all 71 patients who had significant titres 
to the Widal test at the time of sample collection. Thirty eight of these 
patients already treated with one or more of the commonly used antibiotics 
for treatment of enteric fever ,namely chloramphenicol, ciprofloxacin and 
ampicillin. Twenty three patients were treated with one antibiotic,8 with 
tow antibiotics while 7 had received three antibiotics. The remaining 33 
patients did not start any treatment.  Chloramphenicol was the most 
commonly used antibiotic followed by  ciprofloxacin.             
Blood specimens, clotted blood, and freshly passed stool were 
collected from patients clinically diagnosed as having enteric fever. 
Specimens were labelled, kept and transferred immediately to the 
laboratory for bacteriological examination. 
3.2.4 Cultural Methods:  
3.2.4.1 Blood culture: - 
Five ml of venous blood was taken from every patient and put 
immediately in a culture bottle using Castañeda method, where, a double 
medium was used, containing bile broth with agar slant on the side. After 
the incubation of blood, the bottle was incubated in the upright position. 
For the subculture, the bottle was merely tilted so that the broth runs onto 
the surface of agar. It was reincubated in the upright position. If Salmonella 
was present, colonies would appear in the slant side. A second subculture 
was performed on brilliant green bismuth sulphite agar, MacConkey agar 
and Salmonella-Shigella agar media. It was incubated at 37 C for another 
24-48 hours. After that the plates were followed up for growth. If there 
have been growth non-lactose fermenters in (SSA), sometimes with clear 
edge and black colonies with metallic sheen in BBSA, then Salmonella has 
to be strongly suspected and further identification tests were performed.                
3.2.4.2 Clot culture: - 
Five ml of blood were withdrawn from the patient into a sterile test 
tube and left to clot. The serum was pippetted off and used for the Widal 
test. The clot was broken up with a sterile glass rod and added to a bottle of 
bile broth. Subculture was transferred onto SSA and BBSA.      
3.2.4.3 Faeces culture: - 
Freshly passed stool was collected in a stool container. 
 First day: A suspension of sample in saline was used to inoculate 
plates of Salmonella-Shigella Agar (SSA), Brilliant green bismuth 
sulphite agar (BBSA), and a bottle of selenite–F-broth, and then 
all were incubated at 37 C for 18-24 hours. 
 Second day: The Selenite–F-broth was used to inoculate plates of 
Salmonella Shigella Agar (SSA) and Brilliant green bismuth 
sulphite (BBSA). 
 Third day and on wards: 
Colonial morphology was observed for the presumptive colonies. Gram 
stain was done for these colonies followed by motility testing and 
biochemical tests which include indole production test, Simmons’s citrate, 
Voges Proskauer (VP), methyl red (MR), urease test and nitrate reduction 
test. 
Carbohydrate fermentation test were performed for further 
identification of the microorganism.  
3.2.5 Examination of Cultures: 
Cultures, which were semi-quantitatively determined as conforming 
to the concept of significant bacterial growth (i.e. presence of 100 or more 
colonies on the plate culture, because of the use of nichrome loop holding 
0.001 ml), were subjected to further identification. 
All cultures were examined with the naked eye for growth and 
colonial morphology as well as any changes in the media. Plates, which 
showed visible growth, were subjected to subsequent bacteriological tests. 
Those which with no visible growth, were reincubated and examined daily 
for up to 7 days. 
3.2.5.1 Purification of Isolates: 
The primary isolates were subcultured on nutrient agar. This was 
achieved by several subcultures of a typical and a well-isolated colony 
from the corresponding medium. The process was repeated till purification 
was achieved. The resulting growth was checked for purity by Gram’s stain 
and examined microscopically. 
 
  3.2.5.2 Identification of the Isolated Bacteria: 
3.2.5.2.1 Primary Identification: 
Gram’s staining to see the shape, arrangement and Gram’s reaction 
were performed for primary identification. 
Bacterial smears were prepared by emulsifying a small inoculum of 
the bacterial culture in a drop of normal saline and spreading it onto a clean 
glass slide (15-20 mm). The smears were allowed to dry on air and then 
fixed by gentle heating. 
3.2.5.2.1.1 Gram’s Stain: 
Gram’s stain was applied according to Ochei and Feltham (2000). 
The slides (smears), were placed on the staining rack and were flooded 
with crystal violet stain (base stain), for 1 minute, then the stain was 
washed off with distilled water. The smears were covered with Lugol’s 
iodine (mordant) for 1 minute, and then washed. Acetone was used for the 
decolourization for 1-2 seconds, and then rinsed in distilled water. The 
smears were counter stained with safranin for 1 minute, rinsed in water, 
blotted with filter paper and allowed to air-dry. The prepared slides were 
examined microscopically with oil immersion lens objective. Bacteria 
coloured violet was labelled as Gram positive and red-coloured bacteria 
were labelled Gram negative. 
3.2.5.2 Secondary Identification of Isolated Bacteria: 
This was done by using the biochemical tests, which were performed 
according to Barrow and Feltham (1993). 
3.2.5.2.1 Oxidase Tests: 
A piece of filter paper approximately 2 cm in diameter, 5 cm in 
length was placed in a petri dish and 2-3 drops of the solution of 
tetramethyl-p-phenylene diamine dihydrochloride were added. A small 
portion of the tested organism culture was picked with a sterile bent glass 
rod and rubbed on the filter paper. A dark purple colour that developed 
within 5-10 seconds was considered as a positive result. 
3.2.5.2.2 Sugar Fermentation Tests: 
The sugar media were inoculated with the test organisms and 
incubated at 37 C overnight. They were examined daily for 7 days. Acid 
production was indicated by the development of a pink colour in the 
medium. Gas production was indicated by air trapped in the Durham’s 
tube. The sugars used in these tests were glucose, lactose, salacin, sucrose, 
maltose and mannitol. 
3.2.5.2.3 Indole Test: 
The tested organism was inoculated in peptone water and incubated 
at 37C for 48 hours. Then 0.5 ml of Kovac’s reagent was added. To 
indicate indole the tube was shaked well and examined after one minute. 
The production of a red colour on the upper layer of the reagent indicated 
indole production. 
3.2.5.2.4 Voges-Proskauer (V.P) Test: 
The test was used to detect the production of acetyl-methyl carbinol. 
Glucose phosphate peptone medium was inoculated with the test organism 
and incubated at 37C for 48 hours. Then 0.6 ml of 5% alpha-naphthol 
followed by the addition of 0.2 ml of 40% potassium hydroxide aqueous 
solution to one ml of the culture, shaken well and examined after 15 
minutes and one hour. A bright pink colour indicated positive reaction. 
3.2.5.2.5 Methyl Red Test: 
The test was made to detect the production of prolonged acidity from 
glucose in buffered medium. Glucose phosphate peptone medium was 
inoculated with the tested organism. The inoculated tubes were incubated at 
37C for 48 hours. Five to six drops of methyl red solution were added and 
the tube was then shaked. The development of red colour indicated a 
positive result. 
3.2.5.2.6 Urease Test: 
The tested organism was inoculated on a slope of urea agar medium 
and incubated at 37C for 24 hours. A change in colour of the medium to red 
was considered positive. 
 
3.2.5.2.7 Nitrate Test: 
The test organism was grown in nitrate broth and incubated at 37C 
for up to 5 days. One ml of nitrate reagent A was added followed by 1 ml 
of reagent B. A deep red colour indicated a positive test of nitrate 
reduction. To tubes that did not show red colour within 5 minutes, were 
treated with powdered zinc and allowed to stand. The formation of a red 
colour indicated that nitrate was present but the tested was not reduced by 
the organism. 
3.2.5.2.8 Citrate Utilization Test: 
Tubes of Simmons’s citrate medium were inoculated with the tested 
organism by stab inoculation. The inoculated tubes were incubated at 37C 
for 24 hours. Positive results were indicated by change in the colour of the 
medium to blue. When there was no change in colour occurred, i.e. green), 
the result was considered negative. 
3.2.5.2.9 Motility Test: 
 The motility test was done through inoculating motility media 
(semi-solid media) by stabbing with a bacteriological needle. Tubes were 
incubated at 37C for 24 hours. The tested organism was considered motile 
when it formed a diffuse growth inside the medium. Non-motile organisms 
were those with growth along the stab area (line) only.   
 
 
3.2.6 Susceptibility to Antibiotics: 
All isolated bacteria were examined for their susceptibility to a 
number of antibiotics by disc diffusion technique (Kirby-Bauer method). 
The isolate was grown in peptone water and incubated at 37C for 24 hours. 
A sterile cotton swab immersed into the growth was used to inoculate a 
plate of Diagnostic Sensitivity Test (DST) agar medium. The inoculation 
was evenly distributed all over the plate. Commercially prepared antibiotic 
discs of Plasmatic Ltd., UK were placed on the surface of the medium 
using sterile forceps. Discs were gently pressed to ensure full contact with 
the medium. Plates were incubated at 37C for 24 hours. The zone of growth 
inhibition around each disc was measured in millimetres and the result was 
reported sensitive, intermediate or resistant. Antibiotics used in 
susceptibility test were ciprofloxacin (5µg), chloramphenicol (30 µg), 
trimethoprim (10 µg), ampicillin (10 µg), co-trimoxazole (10 µg) and 
nalidixic acid (10 µg). 
3.2.6.1 Interpretation of the susceptibility test 
Inhibition zones of the test organisms were compared with those 
of the reference organisms they were S. typhi (ATCC St. 19430) from 
American Type of Culture Collection (ATCC) (USA), and S. paratyphi B 
from (National Collection of Type Culture (NCTC) (UK). The zones were 
measured by laying a millimetre ruler across the dish. Provided that the 
inoculum was optimal, results were interpreted and reported as follows: 
• Sensitive: inhibition zone radius was equal to or wider than 
3mm, yet smaller than the control by not more than 3mm. 
•   Intermediate inhibition zone radius was wider than 2 mm 
yet smaller than the control by more than 3 mm. 
• Resistant:  inhibition zone radius was 2 mm or less.     
3.2.7 API System: 
All isolated bacteria were subjected to API system of identification 
to confirm primary and secondary identification; API-20E system was 
employed to identify members of the family enterobacteriacae.  
A plastic strip holding twenty mini-test tubes was inoculated with a 
saline suspension of a pure culture (according to manufacturer’s directions 
from BioMerieux, Inc. Hazelwood, MO, France). This process rehydrated 
the already desiccated medium in each tube. Few tubes were completely 
filled and some tubes were overlaid with mineral oil so that anaerobic 
reactions could be carried out. 
After incubation in a humidity chamber at 37C for 18-24 hours, the 
colour reactions were read out, and the reactions were converted to a seven-
digit code. The code was checked in the manufacturer’s manual to obtain 
the identification result, usually as genus and species with the 
corresponding percentage of identification. 
 
3.2.8 Cases taken into consideration: 
From all blood specimens, beside the bacteriological 
investigation, a blood film was tested for malarial infection and 
similarly from faeces specimens were tested for schistosomal 
infections. A wet mount technique was applied.  
        
 
 
 
 
 
 
  
 
  
CHPTER FOUR 
4.Results 
Out of 71 individual stool specimens that were collected from 
patients with significant titre to Widal test and cultured aerobically,47 
specimens gave growth to Salmonella species, of the remaining 24 the only 
non lactose fermenting bacteria isolated were Proteus species (16 isolates) 
and Pseudomonas species (five isolates). Of clotted blood specimens 33 
gave growth to Salmonella species, 18 specimens gave growth to other 
types of bacteria and 6 specimens gave no growth. Of venous blood 
specimens 18 gave growth to Salmonella species, 15 specimens gave 
growth to other types of bacteria and 9 specimens gave no growth (table 1). 
Salmonella was not noted from any of the patients showing significant 
titres to S.typhi alone.  
Table (1): Bacteria isolated from different specimens 
obtained from 71 patients with significant titre to Widal test  
Type of specimen Bacteria 
isolated                 
Stool 
 
                 
Clotted blood 
             
Venous blood  
S .typhi 0 0 0 
S. paratyphi B 47 33 18 
Proteus 16 11 12 
Pseudomonas 5 7 3 
No growth 0 6 9 
 
 
All Salmonella isolates were completely identified 
biochemically as  Salmonella paratyphi B. Results of 
biochemical tests used for the identification of suspected 
Salmonella isolates are shown in table (2). Some of these 
isolates were sent to the National Health Laboratory 
(Khartoum) for confirmation and the results were consistent 
with these obtained in this study. 
Table (2): Biochemical reactions of Salmonella isolated from patients & 
those of reference strains Salmonella typhi (ATCC 19430), and 
Salmonella paratyphi B (NCTC 15632). 
 
Control organisms Test 
S.typhi S. paratyphi B
Salmonella 
isolates      
Motility + + + 
Indole - - - 
Citrate  - + + 
Vogues 
Proskaeur 
(VP) 
- - - 
Methyl Red 
(MR)  + + + 
Nitrate  + + + 
Oxidase - - - 
Urease - - - 
H2S (KIA) + + + 
Glucose +(A) +(AG) +(AG) 
Lactose - - - 
Maltose +(A) +(AG) +(AG) 
Mannitol +(A) +(AG) +(AG) 
Salacin - - - 
Sucrose - - - 
ATCC= American Type of Culture Collection (USA).  
NCTC=National Collection of Type Culture (UK). 
A= acid, AG= acid and gas. 
(+)= positive (-)= negative. 
Of the 47 S. paratyphi B isolates, 34 (72.4. %)   isolates were from 
female patients and only 13 (27.6%) isolates were from male patients (table 
3). 
 
Table (3): Isolation of S.paratyphi B According to Gender 
 
Male Female Total Isolated 
Organism No % No % No % 
S.paratyphi B  13 27.7% 34 72.3% 47 100% 
 
 
Out of 38 specimens collected from patients previously treated 
with one or more of the commonly used antibiotics for treatment of enteric 
fever, 22 specimens gave growth to S. paratyphi B, 10 specimens gave 
growth to other types of bacteria and six specimens gave no growth. The 
remaining 33 specimens which were collected from patients who did not 
receive antibiotics, 24 specimens gave growth to S.paratyphi B, six gave 
growth to other types of bacteria and three specimens gave no growth(table 
4). 
Table (4):  Isolation of bacteria from treated or untreated patients with 
antibiotics  
 Bacterial 
isolation 
Specimens from Patients who 
received antibiotics             
 
Specimens from Patients 
who did not received 
antibiotics             
 
S. paratyphi B 22 24 
Other type of 
bacteria 
 
10 
 
6 
No growth 6 
 
3 
 
Total 38 33 
In addition to bacteriological culture, all blood specimens were 
tested for malaria. Twenty three specimens gave positive blood film for 
malaria parasites but blood specimens and stools from these patients were 
negative for Salmonella.  Stools were also tested for Schistosoma parasites 
and 19 patients were found to have simultaneous infection with 
Schistosoma parasites and S. paratyphi B. 
All 47 isolates of Salmonella paratyphi B were subjected to in 
vitro antimicrobial susceptibility tests using the disc diffusion method. The 
drugs used were chloramphenicol (30 µg), ciprofloxacin (5µg), nalidixic 
acid, co-trimoxazole (10 µg), trimethoprim (10 µg), and ampicillin (10µg). 
Table (5) shows the susceptibilities of isolates to different antimicrobial 
agents. Of the 47 strains examined 9(19.2 %) strains showed resistance to 
five antimicrobial agents namely ciprofloxacin, ampicillin, trimethoprim, 
co-trimoxazole, and nalidixic acid. Fourteen isolates (29.8%) showed 
resistance to ciprofloxacin while 21 isolates (44.7%) showed resistance to 
co-trimoxazole. Most  strains were resistant to ampicillin; 36 isolates 
(76.6%), whereas none of the isolates was resistant to chloramphenicol.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig (1) showing mucoid colonies of S. paratyphi B with the 
characteristic metallic sheen on brilliant green bismuth sulphate agar. 
 
 
 
        
CHAPTER FIVE 
      5. Discussion 
Human carriers are responsible for S .typhi infections in man (Mac 
Sween, 1992).  According to Cheesbrough in (2000), S. paratyphi B can 
infect animals such as dogs or cows, which may act as sources for the 
human disease. So far, there are no reports of transmission of enteric 
fever from animals to the humans in Gadarif State. Infection takes place 
through ingestion of the organism from contaminated hands. Salmonella 
typhi is mainly water-borne, whilst S. paratyphi is mainly food-borne. In 
the present study it was found that S. paratyphi B, was the species 
commonly involved in enteric infections. Transmission was probably via 
contaminated food or carriers, as community, household and personal 
hygiene were poor. It was observed in this study that enteric fever was 
more prevalent in women than men. This observation is similar to that of 
Paniker and Vilma (1997), who reported that the development of the 
carrier state was common in women.    
One of the most menacing problems that confront the 
epidemiological control of enteric fever is the phenomenon of carriers 
and chronic carriers. As reported by MacSween in (1992), despite 
recovery from the acute phase of the disease, some individuals continue 
to excrete the organism in the faeces and less often in urine. Mandell 
(1985) observed that the excretion of organisms in stool of  patients with 
enteric fever could persist from weeks to more than a year after recovery 
from the disease or after initial discovery of organisms in stool of 
chronic carriers. Johnson (1996) noted that the incidence of chronic 
enteric carrier state after typhoid fever was 1-3%. Chronic carriers are 
unidentified reservoirs and it appears that they may play a fundamental 
role in dissemination of the disease in Gadarif State. Patients with 
Schistosoma haematobium involvement in the urinary tract tend to 
become chronic urinary carriers for enteric fever organism and may 
continue to excrete large numbers of bacilli in urine for months or a year 
Mandell (1985). Schistosomiasis is common in Gadarif State and the 
development of urinary carriers of enteric bacilli is likelihood. Such 
carriers may play a role in the epidemiology of the disease. The 
identification of carries in Gadarif State and similar areas in the Sudan 
remains a problem with no perspective of resolution because  the Widal 
test is of no value in the detection of carriers in endemic countries. The 
identification of faecal carriers is by isolation of the bacilli from faeces 
or from bile. Rowe (1997), suggested that culture of bile obtained by 
duodenal aspiration is usually positive and may be employed for the 
detection of carrier. The tracing of carriers in cities may be accomplished 
by screening food handlers and cooks. Testing for the presence of 
antibody to the Vi antigen has been suggested as a mechanism for 
screening for typhoid carriers. In this study, diagnostic identification of 
carriers was difficult, since detection by culturing for every suspected 
case was out of question, and so testing for antibodies against Vi 
antigens due to limited facilities in Gadarif State. 
Widal test based on bacterial agglutination, is the most widely 
used test for diagnosis of enteric fever, however it is neither specific nor 
sensitive (Lim, 1998). It is popularly used due to the fact that it is simple 
and inexpensive. In Gadarif State Widal test proved excessively 
unspecific, for it frequently gave false-positive reactions in culturally 
negative patients. Enterobacteria having similar antigenic determinants 
to salmonellae causing enteric fever may stimulate production of 
antibodies that may cross react in the Widal test (Stratton, 2001). 
Cheesbrough (2000) asserted that the Widal test was entirely not 
specific, although it was highly sensitive, so its value in diagnosing 
enteric fever in endemic areas remains controversial.  
Some of the blood specimens included in this work were found  
positive by the blood film test for malaria. Flagellar (H) antibodies of 
enteric fever bacilli persist long after recovery and their formation may 
again be stimulated, non-specifically, in subsequent febrile illnesses 
(Stockes, 1993). It was possible that malaria parasites elevated, non-
specifically, the H titres in some patients included in this study thus 
affecting results of the serological test.   
Serological diagnosis of enteric fever was much used in the past 
when effective selective media were not available and it was more difficult 
to isolate the causal, Salmonella species Collee (1996). In this study, 
following serological diagnosis, confirmation was made by using highly 
selective media for the detection of S. typhi and S. paratyphi B. Out of the 
71 specimens that gave significant titres to Widal test, only 47 showed 
growth of the causal pathogens of enteric fever in the culturing media, i.e. 
66.1% of all the samples. This means that the Widal test cannot be regarded 
as a standalone method; it should be followed by culturing in highly 
selective media for the detection of the causal bacteria of enteric fever. In 
such cases, the Widal test will function only as a primary step for diagnosis 
for its simplicity and because it gives fast results. In developing countries 
where typhoid fever is endemic and there are few microbiology 
laboratories to provide diagnosis by culture, the search should continue 
forth for non-cultural techniques that provide rapid and reliable diagnosis 
(Okome et al.,2000).    
Emergence of multidrug-resistant enteric pathogens has remained 
a concern. Brown (2003) documented the emergence of multidrug-
resistant Salmonella paratyphi B in Canada; similar observations were 
made by Van Pelt in the Netherlands, and by Mitchell and co-workers in 
Scotland (2004). In the present work, it was found that Salmonella 
paratyphi B, which is the major causal of enteric fever in Gadarif State, 
developed drug resistance. Of 47 isolates from El-fao, Gadarif, and El- 
hawata regions 29.8%were not susceptible to ciprofloxacin, the drug of 
choice for treatment of enteric fever in the area. The isolates, also, 
displayed a resistance to co-trimoxazole and ampicillin. Mulvey (2004) 
was performed antimicrobial susceptibility testing on strains of 
Salmonella paratyphi B. Susceptibilities were determined for ampicillin, 
chloramphenicol, ciprofloxacin, streptomycin, sulfamethoxazole, 
tetracycline , and trimethoprim. and found that some isolates displayed 
resistance to five of commonly used antibiotics, which were ampicillin, 
chloramphenicol, streptomycin, sulphamethoxazole, and tetracycline. In 
view of the findings of the current study, it is suggested that 
chloramphenicol should be considered the drug of choice for treating 
cases of enteric fever in Gadarif State, as the isolated S. paratyphi B 
exhibited no resistance to this drug.  
One of the most serious complications of enteric fever is relapse. 
Antimicrobial therapy may increase the rate of relapse occurrence. The 
relapse rate was found to be doubled in patients receiving 
chloramphenicol therapy for 2 weeks yet to a less extent with co-
trimoxazole, ampicillin probably did not affect the rate of relapse 
(Pyatkin and Krivochein, 1987). Studies by Paniker (1997) proved that 
the relapse rate went as high as (15-20%), in patients treated with 
chloramphenicol. Convalescence was observed to be slow and in about 
5-10% of the cases where the relapses occurred during convalescence.  
The antibiotics commonly used in Gadarif State were 
chloramphenicol, ciprofloxacin and ampicillin. In this study it was 
observed that some patients complaining from recurring enteric fever. It 
was found through questionnaires that, 38 patients (53.5%)   under study 
who had a previous infection and were treated with commonly used 
antibiotics complained from recurrence. It is noticeable that 
chloramphenicol was administered in most of these cases, followed by 
ciprofloxacin. Ampicillin was administered in rare cases.      
Whether multidrug-resistant Salmonella paratyphi B is a more 
disseminating organism or otherwise, the underlying question remains; 
why did salmonella paratyphi B emerged as a main causative agent of 
enteric fever in Gadarif State. It may be attributed to poor sanitation in 
El-fao region. Other factors such as contaminated milk and its products 
obtained from infected animals could play a role in disseminating this 
organism. It has been suggested that schistosomiasis may simultaneously 
be associated with Salmonella infections. Nineteen of the patients 
included in this study (40.4%) had schistosomiasis. The  schistosomes 
may contribute to the dissemination of organism and development of 
carrier state. This has been pointed out by Cheesbrough (2000) who had 
explained that the Salmonella organisms colonised adult flukes, thus 
being protected from antibiotics and provide questions of a brooding 
danger on the epidemiological control, detection, diagnosis, and 
treatment of enteric fever. In other words, Salmonella is transmitted 
through a vector, which may be itself endemic in irrigated areas and 
areas of non-hygienic water supply sources. Gendrel (1993), reported 
that Schistosoma–Salmonella interactions had been described with all 
species of Schistosoma, The adult of which lives in the mesenteric 
venous plexuses, Salmonellae are stuck onto its outer wall. As a result of 
this, Salmonella septicaemia facilitated and supported by schistosomal 
infection, and several varieties of Salmonella may be involved. These 
Salmonella infections cannot be cured without the treatment of the 
associated schistosomiasis. It is suggestible that the shedding of 
Salmonella accompanies the excretions of the fluke. In such cases, 
Salmonella often appears to be resistant to antibiotic therapy and 
recurrent typhoid fever is not uncommon in patients infected with 
Schistosoma. A study carried out by Okome and co-workers on patients 
suffering typhoid or paratyphoid fever, in Libreville, the capital of 
Gabon in (2000), documented that the incidence rates of salmonellosis 
associated with schistosomiasis composed a rate of infection exceeding, 
amongst others, the HIV infection. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 CHAPTER SIX  
Conclusions and Recommendations: 
6.1 Conclusions: 
• enteric fever appears to be endemic in the area in the vicinity of 
Gadarif State, Eastern Sudan. 
• Salmonella enterica  serotype paratyphi B was the main cause of 
the disease and   S. enterica  serotype typhi has not been isolated. 
• Growing drug resistance of S.paratyphi B to commonly used 
antibiotics was noted especially to the drug of choice, 
ciprofloxacin.  
• Some patients infected simultaneously with Schistosoma and 
S.paratyphi B did not respond to antibiotics, possibly because   
Salmonella invades the adult fluke of Schistosoma and become 
protected from antibiotics.  
• Widal test proved to be unreliable for diagnosis of enteric fever as 
its titres  elevated significantly in patients suffering from malaria. 
6.2 Recommendations:  
The following recommendations are relevant .  
• Adoption Plans for Health education in Gadarif State particularly 
in community health, personal health, hygiene and careful disposal 
of waste (cow dung) and compost – through incineration or 
through any convenient methods. 
• Establishment of laboratories competent in cultural techniques for 
the identification of the pathogens. 
• Treatment of schistosomiasis prior to enteric fever to avoid 
complications created by possible Salmonella-Schistosoma 
association. 
• Carrier-state is considered a major issue in the dissemination of 
enteric fever; better methods for early detection of carriers should 
be developed. 
• Abuse of commonly used antimicrobials should be banned.  
• Vaccination against enteric fever should be considered.    
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Appendix (1) 
Questionnaire about typhoid fever in Gadarif State 
 
Patients name:  ….    ….    ….    ….    ….    ….    ….    ….    ….    …. 
Age:                  ….    ….    ….    ….    ….    ….    ….    ….    ….    …. 
Residence:        ….    ….    ….    ….    ….    ….    ….    ….    ….    …. 
 
 
Causative agent according to Widal test  
      
1.  Salmonella typhi  
 
  
 2. Salmonella paratyphi B  
           
Antibiotics received in previous infection: 
 
….    ….    ….    ….    ….    ….    ….    ….    ….    ….    ….    ….    ….      
….    ….    ….    ….    ….    ….    ….    ….    ….    ….    ….    ….    ….        
….    ….    ….    ….    ….    ….    ….    ….    ….    ….    ….    ….    ….        
….    ….    ….    ….    ….    ….    ….    ….    ….    ….    ….    ….    ….         
Type of specimen collected: 
….    ….    ….    ….    ….    ….    ….    ….    ….    ….    ….    ….    ….        
Infection with other febrile illness: 
….    ….    ….    ….    ….    ….    ….    ….    ….    ….    ….    ….    ….         
….    ….    ….    ….    ….    ….    ….    ….    ….    ….    ….    ….    ….         
 
 
Date of  specimen collection:        ….    ….    ….    ….    ….    ….    ….     
 
 
 
 
 
 
 
 
 
 
Appendix (2) 
SCHEME FOR IDENTIFICATION OF SALMONELLA 
                  SPECIES SUGGESTED BY F.J BAKER 
 
 
On MacConkey medium 
                                                                                     
                                                                                     
                                                                                      
                                      Non lactose fermenting colonies 
                          
                                                             
Stage (1) 
1- Oxidase test positive almost Pseudomonas species 
                                                             
 
                                                 If negative 
2- Urease test if positive almost Proteus species 
                                                               
 
                                                  If negative     
3- Indole test if positive almost Shigella species 
                                                                             
 
4- Motility test if positive suggestive of Salmonella species (except 
S.          galinarum- pullurum) 
 
 
Stage (2)  
             
               Glucose (fermentation with acid and gas) 
               Mannitol (fermentation with acid and gas)  
               Maltose (fermentation with acid and gas) 
               Sucrose (no fermentation)  
               Lactose (no fermentation) 
               Salacin (no fermentation) 
 
Most probably Salmonella species 
 
 
 
